Social Support and the Prevalence of Depressive and Anxiety Disorders in Low -Income Adults With Type 2 Diabetes and Other Chronic Illnesses. by Thomas, Janet Leigh
Louisiana State University
LSU Digital Commons
LSU Historical Dissertations and Theses Graduate School
2001
Social Support and the Prevalence of Depressive
and Anxiety Disorders in Low -Income Adults
With Type 2 Diabetes and Other Chronic Illnesses.
Janet Leigh Thomas
Louisiana State University and Agricultural & Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact
gradetd@lsu.edu.
Recommended Citation
Thomas, Janet Leigh, "Social Support and the Prevalence of Depressive and Anxiety Disorders in Low -Income Adults With Type 2
Diabetes and Other Chronic Illnesses." (2001). LSU Historical Dissertations and Theses. 437.
https://digitalcommons.lsu.edu/gradschool_disstheses/437
INFORMATION TO USERS
This manuscript has been reproduced from the microfilm master. UMI films 
the text directly from the original or copy submitted. Thus, some thesis and 
dissertation copies are in typewriter face, while others may be from any type of 
computer printer.
The quality of this reproduction is dependent upon the quality of the 
copy submitted. Broken or indistinct print, colored or poor quality illustrations 
and photographs, print bleedthrough, substandard margins, and improper 
alignment can adversely affect reproduction.
In the unlikely event that the author did not send UMI a complete manuscript 
and there are missing pages, these will be noted. Also, if unauthorized 
copyright material had to be removed, a note will indicate the deletion.
Oversize materials (e.g., maps, drawings, charts) are reproduced by 
sectioning the original, beginning at the upper left-hand comer and continuing 
from left to right in equal sections with small overlaps.
Photographs included in the original manuscript have been reproduced 
xerographically in this copy. Higher quality 6" x 9” black and white 
photographic prints are available for any photographs or illustrations appearing 
in this copy for an additional charge. Contact UMI directly to order.
Bell & Howell Information and Learning 
300 North Zeeb Road, Ann Arbor, Ml 48106-1346 USA 
800-521-0600
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
SOCIAL SUPPORT AND THE PREVALENCE OF DEPRESSIVE AND ANXIETY 
DISORDERS IN LOW-INCOME ADULTS 
WITH TYPE 2 DIABETES AND OTHER CHRONIC ILLNESSES
A Dissertation
Submitted to the Graduate Faculty of the 
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfillment of the 
requirements for the degree of 
Doctor of Philosophy
in
The Department of Psychology
by
Janet Leigh Thomas 
BA, University of California, Riverside, 1986 
MSW, San Diego State University. 1990 
MA, Louisiana State University, 1999 
December, 2001
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
UMI Number 3042653
___ _®
UMI
UMI Microform 3042653 
Copyright 2002 by ProQuest Information and Learning Company. 
All rights reserved. This microform edition is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest Information and Learning Company 
300 North Zeeb Road 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ACKNOWLEDGEMENTS 
I would like to take this opportunity to acknowledge and thank some of the 
individuals who have made this dissertation possible. My deepest gratitude goes to Dr. 
Phillip Brantley, for accepting me into the program and inspiring a genuine love of 
research. For the past four years, he has contributed to my professional and personal 
development by challenging, encouraging and supporting my academic endeavors. I 
believe I am a better person for having his guidance and I look forward to his 
mentorship throughout my career. I am also indebted to Dr. Glenn Jones who has 
shared with me his wealth of computer and statistical knowledge. In addition to being a 
consultant, he has been a great source of support, a confidant and an all-around great 
friend. I would also like to take this opportunity to thank my dissertation committee 
members: Drs. Phillip Brantley, Mary Lou Kelley, Bill Waters, Mike Hawkins and 
Glenn Jones. I thank them for their support and relevant input. A special thanks goes 
to Ms. Sally Allen and Ms. Reba Rosenbaum for their kindness, patience, knowledge 
and consistent support throughout the past 5 years. Without them, would any of us ever 
finish??! I also wish to thank my friends: Dr. Gina Manguno-Mire, Tana Hope, Mike 
Fahmey and Clave Goodhope for keeping me sane and for helping me survive graduate 
school. And lastly, I acknowledge my brother, Steve Thomas and my parents, Donald 
and Eleanor Thomas, for their love and encouragement throughout my academic 
endeavors.
ii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
TABLE OF CONTENTS
ACKNOWLEDGEMENTS....................................................................................... ii
LIST OF TABLES...................................................................................................... vi
LIST OF FIGURES....................................................................................................viii
ABSTRACT................................................................................................................ix
INTRODUCTION......................................................................................................1
REVIEW OF THE LITERATURE........................................................................... 6
Diabetes Mellitus............................................................................................ 6
Definitional Aspects........................................................................... 6
Epidemiological Aspects....................................................................11
Etiological Aspects............................................................................ 15
Behavioral Risk Factors..................................................................... 19
Psychopathology in Primary Care..................................................................21
Depression in the Primary Care Setting............................................22
Anxiety in the Primary Care Setting...................................................24
Psychopathology and Diabetes Mellitus........................................................ 26
Depression and D M ...........................................................................28
Anxiety and DM ................................................................................ 33
Social Support............................................................................................... 35
Social Support and Stress....................................................................37
Social Support and Medical Illness....................................................38
Social Support and DM.......................................................................40
PURPOSE OF STUDY.............................................................................................. 44
Summary.........................................................................................................44
Research Questions and Hypotheses.............................................................46
Purpose I: Prevalence of Depressive and Anxiety Disorder
Diagnoses.......................................................................................... 46
Purpose 2: Direct Effect of Social Support as a Predictor
of an AD............................................................................................. 46
Purpose 3: Social Support as a Moderating Variable Between
IG and AD.......................................................................................... 47
Purpose 4: Predictive Utility of Each Type of Social Support 47
iii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
METHODS ...............................................................................................................49
Participants ..................................................................................................49
Measures .................................................................................................. 49
Demographic Questionnaire................................................................ 49
Medical Chart Review......................................................................... 49
Diagnostic Interview Schedule for DSM-IV (DIS-IV)......................50
Interpersonal Support Evaluation List (ISEL).....................................51
Procedure...........................................................................................................52
Preliminary Power Analyses............................................................................54
RESULTS......................................................................................................................57
Preliminary Descriptive Analyses................................................................... 57
Demographic Data...............................................................................57
Measurement Data (ISEL)................................................................... 59
Power Analyses................................................................................................ 60
Power of Chi-Square Analyses........................................................... 60
Power of Logistic Regressions Analyses........................................... 61
Preliminary Descriptive and Inferential Analyses......................................... 63
Medical Illness Groups....................................................................... 64
Diagnostic Groups...............................................................................67
Affective Disorder Groups.................................................................. 70
Preliminary Logistic Regression..................................................................... 73
Main Analyses.................................................................................................. 74
Data Analyses.......................................................................................74
Purpose I : Prevalence of Depressive and Anxiety Disorder
Diagnoses............................................................................................ 74
Purpose 2: Direct Effect of Social Support as a Predictor
of an AD................................................................................................78
Purpose 3: Social Support as a Moderating Variable Between
IGandAD.............................................................................................79
Purpose 4: Predictive Utility of Each Type of Social Support.......... 8 1
DISCUSSION............................................................................................................... 83
Prevalence of Affective Disorders................................................................... 83
Type 2 DM Vs. Other Chronic Illnesses in the Incidence of AD...................88
Social Support................................................................................................... 90
Intervention Implications..................................................................................94
Limitations and Future Directions................................................................... 95
Summary............................................................................................................97
REFERENCES.............................................................................................................99
APPENDIX A: DEMOGRAPHIC QUESTIONNAIRE............................................119
iv
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
APPENDIX B: INSTITUTIONAL REVIEW BOARD APPROVAL..................... 121
APPENDIX C: INFORMED CONSENT FORM..................................................... 122
APPENDIX D: DEMOGRAPHIC PROFILE OF THE ORIGINAL......................125
APPENDIX E ............................................................................................................. 126
Figure 4: Linear Model o f Social Support (X) as a Moderating
Variable Between Illness Group and Affective Disorders as
Determined by Logged Odds (B).....................................................................126
Figure 5: Odds of Having an Affective Disorder Diagnosis for
Females with 11.3 Years of Education for Each Illness Group
with Social Support as a Moderating Variable............................................... 127
VITA..............................................................................................................................128
v
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF TABLES
1. Timeline of Administration of Measures................................................... 53
2. Power Analysis for 3X4 Chi-Square (Power = 79).................................. 54
3. Power Analysis for a Single Categorical LR Analysis
(Power = .88)...............................................................................................55
4. Power Analysis for a Single Continuous LR Analysis
(Power = .70)...............................................................................................56
5. Demographic Data for the Sample (N = 326)
(Categorical Variables).............................................................................. 59
6. Demographic Data for the Sample (N = 326)
(Continuous Variables).............................................................................. 59
7. Means and Standard Deviations of the Normative Data and
Sample Data for the ISEL Total and Subscale Scores...............................60
8. Percentages, Number of Cases, and Chi-Square Significance 
of Categorical Demographic Variable for Medical
Illness Group (N=32 6 ) .............................................................................. 65
9. Means, SD, F Values, Df and ANOVA Significance of 
Continuous Demographic Variable for Medical Illness Group
(N= 326) .....................................................................................................67
10. Percentages, Number of Cases, and Chi-Square Significance 
of Categorical Demographic Variable for Diagnostic
Group (N = 326) ........................................................................................68
11. Means, SD, Df, F Values and ANOVA Significance of 
Continuous Demographic Variable for Diagnostic Group
(N =326).....................................................................................................70
12. Percentages, Number o f Cases, and Chi-Square Significance 
of Categorical Demographic Variable for Affective
Disorder Group (N = 326).......................................................................... 71
13. Means, SD, Df, F Values and ANOVA Significance of 
Continuous Demographic Variable for Affective Disorder
Group (N=326).......................................................................................... 72
vi
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
14. Preliminary Backward LR of DemographicVariables as Predictors
of AD........................................................................................................... 73
15. Descriptive Statistics and Overall Chi-Square Results of the 
Prevalence of DSM-IV Diagnoses within Medical Illness
Group........................................................................................................... 75
16. Descriptive Statistics and Overall Chi-Square Results of the Prevalence
of an AD for the Total Sample and Within Each Illness Group................76
17. Hierarchical LR Results of Gender. Education and IG .............................77
18. LR Results of Gender. Education, IG, and S S ...........................................79
19. LR Results of Gender, Education. IG, and SS and IG X S S ......................80
20. LR results of Gender, Education. IG and SS Subscales
(Appraisal. Tangible, Self-esteem, Belonging)......................................... 82
21. Results of Gender, Education. IG. Tangible Support and the
Tangible Support X IG Interaction.............................................................82
vii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF FIGURES
1. Power Analysis for 3 X 4 Chi-Square (N = 326)...........................................61
2. Power Analysis for a Single Categorical LR Analysis (N = 326)........... 62
3. Power Analysis for a Single Continuous LR Analysis (N = 326)........... 63
4. Social Support as a Moderating Variable Between Illness Group and
Affective Disorders.......................................................................................... 126
5. Odds of Having an Affective Disorder Diagnosis for Female with 11.3 
Years of Education for Each Illness Group with Social Support as a 
Moderating Variable......................................................................................... 127
viii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ABSTRACT
The present study used a cross-sectional design to answer the following 
questions: (a) what is the prevalence of DSM-IV depressive and anxiety disorders in a 
population of low-income primary care patients with type 2 Diabetes Mellitus (DM), 
and does a diagnosis of type 2 DM contribute to an increased prevalence of affective 
disorders above the rate identified in other chronic illness groups and those suffering 
from no medical diagnoses, (b) does perceived social support, as measured by the 
Interpersonal Support Evaluation List (ISEL) have a direct and/or buffering effect on 
the association between chronic disease and affective disorder diagnoses, and (c) which 
aspects of social support (appraisal, tangible, belonging and self-esteem) serve as the 
best predictors of a diagnosis of an affective disorder in patients with chronic illness. 
The sample included 326 randomly selected adult female patients recruited from 
primary care clinics at a public hospital. The sample consisted predominantly of 
uninsured, African American, low-income, middle-aged females. Logistic regression 
analyses identified a significant main effect for illness group when age and education 
were statistically controlled (X 2 = 22.66, d f  4, p < .000). When posthoc comparisons 
were examined, significant contrast effects occurred when type 2 DM were compared 
with other chronic illnesses. Specifically, the odds of having an affective disorder 
increased in those with type 2 DM by 126%. Logistic regression also identified a 
significant interaction between social support and illness (X~ = 35.42, d f  5, p < .000). 
Results indicated that social support was more beneficial for patients with chronic
ix
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
illness. Each SD decrease in social support increased the odds of having an affective 
disorder by 67° o for the total sample.
Although tangible support was identified as an important buffer for affective 
disorders, emotional sources of support appear to be equally important. Given the high 
prevalence of affective disorders identified in this sample and the beneficial effect of 
social support, intervention implications are suggested for those working in primary 
care settings.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
INTRODUCTION 
The comorbidity o f mental and physical illness is currently of considerable 
interest. It is generally accepted that an increased risk of psychiatric impairment 
accompanies the presence of a medical illness (Schulberg & Bums, 1988; Barrett, 
Barrett, Oxman, & Gerber, 1988; Katon & Sullivan, 1990; Rodin & Voshart, 1986). 
Recent studies suggest that people with Diabetes Mellitus (DM) have higher levels of 
psychological disturbance than exist in the general population (Gavard, Lustman, & 
Clouse, 1993).
According to the results of epidemiological studies, depressive and anxiety 
disorders are more prevalent in patients with DM than in those who are medically 
healthy (Wells, Golding & Brunham, 1989; Weyerer, Hewer, Pfeifer-Kurda, & Dilling, 
1989). Additionally, the results of clinical studies have also shown a high prevalence of 
depressive disorders among patients with diabetes (Frits & Nanjundappa, 1986;
Lustman, Griffith, Clouse & Cryer, 1986; Marcus, Wing, Guare, Blair & Jawad, 1992; 
Popkin, Callies, Lenz, Colon & Sutherland, 1988; Wing, Marcus, & Blair, 1990). 
However, the evidence is contradictory, as there are also results that do not support the 
above conclusion (Robinson, Fuller & Edmeades, 1988; Wells, Golding, et al., 1988b). 
More importantly, prior studies have made biochemical assumptions attributing a higher 
prevalence o f depressive disorders in patients with DM to a shared disturbance in the 
HPA axis; however, evidence that the incidence of depression is higher in patients with 
diabetes than those with other chronic illnesses has yet to be firmly established. In the 
two studies which have compared DM to other illness groups (Wells et al., 1988a; 
Weyerer et al., 1989) DM does not appear to contribute to a greater risk of psychiatric
1
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impairment. Unfortunately, the results of these studies are questionable as the diagnosis 
of DM was not verified by a physician. Additionally, the diabetic samples included 
both type 1 and type 2 DM (Nielson & Williams, 1980; Turner & Noh, 1988; Bennett, 
1994).
Although prior studies have focused on the prevalence of depression in DM, our 
understanding of the incidence of anxiety disorders in patients with DM is more limited. 
Additionally, most prevalence studies have based their conclusion on the results of self- 
report measures of depression and anxiety symptoms, which limit diagnostic specificity. 
Thus, whether depressive and anxiety disorders are more common in type 2 DM than 
other chronic illnesses has yet to be reliably determined in the literature.
Substantial research reveals that personal coping resources may contribute to the 
variable impact of chronic illness on psychological health. Chronically ill patients who 
receive considerable social support have been found to be at decreased risk of 
developing a subsequent depression (Brown, Andrews, Harris, Adler, & Bridge, 1986; 
Holahan & Holahan, 1987). Two models have been proposed to explain the impact of 
social support. The direct-effect model assumes that social support has a beneficial 
effect on psychological health regardless of whether stress (e.g., due to illness) is 
present or not, thus suggesting that the effect of social support is independent of stress 
(Broadhead, Kaplan & James, 1983). According to the buffering model, social support 
mitigates the negative influence of stress on physical and psychological health, thus 
suggesting that its effects are mainly upon stress (Cobb, 1976; Cohen & Syme, 1985).
As most prior studies have been restricted to one specific disease, it has not been 
possible to determine whether the effects of social support differ across people with
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
different illnesses. However, there are some indications that the effectiveness of social 
support may depend on the type of support available and the specific characteristics of 
the disease (Folkman & Lazarus, 1980; Penninx, Kriegsman, van Eijk, Boek, & Deeg, 
1996). For example, emotion-focused support strategies (e.g., expression of sympathy) 
have been found to be more effective in coping with situations that are not amenable to 
individual control (Pearlin & Schooler, 1978). Moreover, the degree of life threat 
(Feifel. Stack, & Nagy, 1987; Rolland, 1987) and the functional incapacitation resulting 
from the illness (Fitzpatrick, Newman, Archer, & Shipley, 1991) are also considered 
critical aspects.
It follows that social support that focuses on decreasing the emotional distress 
caused by a disease may be most beneficial to patients with illnesses that cannot be 
managed by individual or medical intervention. Ell, Nishimoto, Morvay, Mantell, and 
Hamovitch (1989) found that in a life threatening disease, emotional support from 
others appeared to protect patients from developing subsequent psychiatric impairment; 
whereas in patients suffering from illnesses that are functionally impairing, tangible 
support (e.g., task assistance) was found to be a more important determinant of 
comorbid psychopathology (Fitzpatrick et al., 1991). Therefore, as chronic diseases 
have different characteristics regarding prognosis, extent of functional incapacitation 
and amenability to treatment, the corresponding effectiveness of social support as a 
buffering agent may also vary.
Considering that the basic physiological mechanisms for metabolic control may 
be different in type 1 and type 2 DM, and given that the experiences of individuals with 
DM differ according to the characteristics of their disorder and the type of treatment
3
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necessary (Leedom, Meehan, Procci, & Zeidler, 1991), it may be important to study 
psychiatric symptoms in these two patient populations separately. As type 2 DM 
represents 80% of diabetic patients, the present study focused exclusively on patients 
diagnosed with type 2 DM.
Previous research addressing psychological distress among individuals with DM 
has rarely been informed by a theoretically and conceptually driven model that specifies 
the interrelationships among relevant constructs (Connell, Davis, Gallant, & Sharpe,
1994). Therefore, this study attempts to address this limitation by exploring the 
influence of social support in the incidence of affective disorders in patients with 
chronic illness. However, in order to accomplish this goal, the first purpose of this 
study was to compare and contrast the prevalence of anxiety and depressive disorders in 
low-income primary care patients with type 2 DM. against those with other chronic 
illnesses and those with no medical illness. Following this determination, the present 
study explored the effects of social support on diagnosed depressive and anxiety 
disorders across groups. Although prior research has addressed the contribution of 
social support to glycemic control and dietary adherence; no prior studies have 
examined the direct and buffering effects of social support on the presence of affective 
disorders in patients with type 2 DM.
In conclusion, this study provides a unique contribution to the literature by 
conducting a cross-sectional study in a primary care sample consisting primarily of 
economically disadvantaged, urban African Americans with the following objectives:
(1) To compare and contrast the prevalence of diagnosed depressive and anxiety 
disorders in patients diagnosed with type 2 DM, in those with other chronic illnesses
4
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and in those with no comorbid medical illness: (2) to determine the degree to which 
social support contributes to the prediction of a diagnosis of an affective disorder (that 
is, either a depressive or an anxiety disorder) in patients with no comorbid medical 
illness; (3) to determine whether perceived social support serves as a moderator in the 
association of medical illness with diagnosed affective disorder; and (4) to determine 
the type of social support (appraisal, belonging, self-esteem and tangible) most effective 
in moderating the stress associated with medical illness and affective disorders. 
Although a cross-sectional design cannot directly address the issue of cause and effect, 
such a study can provide direction for future research and guidance for clinical 
management.
First, a review of the literature will provide an overview of the definition 
aspects, etiological theories, and epidemiologic evidence pertaining to DM. This 
examination will be followed by a general overview of the issue of psychopathology in 
primary care practice and a detailed examination of the literature pertaining to comorbid 
anxiety and depressive disorders in patients with DM. Finally, there will be a review of 
the social support literature, with special emphasis on the empirical studies examining 
the association between social support and DM.
5
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REVIEW OF THE LITERATURE 
Diabetes Mellitus
Definitional Aspects
Diabetes Mellitus (DM) generally refers to two separate medical conditions 
distinguished by elevated levels of blood glucose: type I and type 2 DM. Other types 
of diabetes (e.g., gestational DM, diabetes insipidus, maturity onset diabetes of the 
young [MODY]) will not be addressed in this review. Both types I and 2 DM are 
characterized by abnormalities in blood glucose metabolism caused by deficiencies in 
insulin production, utilization or both. Abnormal glucose metabolism can lead to 
chronically high (hyperglycemia) or low (hypoglycemia) blood glucose levels. 
According to the American Diabetes Association (1999), blood glucose levels (BG) 
between 70-l20mg/dl are considered normal and a value above or below this range 
represents poor glycemic control. Although both type 1 and type 2 DM are associated 
with long-term complications secondary to poor glucose control, there are significant 
differences between these two complex metabolic conditions.
The major difference between type 1 and type 2 DM lies in the underlying 
pathology and consequent treatment regimens. Individuals with type 1 DM require 
insulin injections to preserve life, as they do not produce endogenous insulin. Insulin 
regimens vary greatly depending on targeted blood glucose control and patient 
motivation. Some patients may require only one or two daily injections, whereas others 
following more intensive insulin regimens may require multiple daily injections or 
insulin pumps for continuous insulin delivery. Daily self-monitoring of blood glucose 
is essential for all patients with diabetes; however, those following more intensive
6
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insulin regimens may require three to five daily finger sticks. Those with type 2 DM 
may use insulin to overcome their bodies' resistance to endogenous insulin, but they do 
not require an external source of insulin in order to survive. Initial treatment for type 2 
DM typically focuses on diet and exercise therapy to reduce weight, thereby decreasing 
insulin resistance. Eventually; however, oral medications and/or injections of insulin 
are frequently necessary to control blood glucose levels.
Hypoglycemia (BG < 70) is a condition attributable to the effects of low blood 
glucose on the central and autonomic nervous systems. Hypoglycemic episodes are not 
unusual for patients with DM who take glucose-lowering medications, such as insulin 
or the sulfonylurea drugs (e.g., glyburide, glipizide). On average, patients with type 1 
DM have one or two episodes of hypoglycemia each week; however, hypoglycemic 
episodes rarely occur in patients with type 2 DM. The cause of hypoglycemia has been 
explained as insulin “doing its job too well” (ADA, 1999, p. 158). In patients without 
DM, the body stops releasing insulin before glucose levels fall too low. However, in 
patients with DM. especially those injecting insulin, there is no shutdown mechanism to 
stop insulin release. Therefore, insulin can deplete the available supply of glucose in 
the blood. Mild hypoglycemic episodes (BG = 50-70) can be treated by ingesting fast- 
acting glucose (i.e. candy, fruit juice). However, these episodes are often disruptive as 
symptoms of low blood sugar typically include shakiness, nervousness, sweating, chills 
and clamminess, rapid heartbeat, trouble concentrating, headache, dizziness, light­
headedness, moodiness, clumsiness, extreme hunger and irritability. More severe 
hypoglycemia (BG < 50) can cause marked neurobehavioral dysfunction and can 
progress to seizures, unconsciousness, coma and eventual death (ADA, 1999).
7
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Alternately, high levels of blood glucose, hyperglycemia, (BG > 120) can also be 
dangerous.
In patients with type 1 DM, hyperglycemia can lead to diabetic ketoacidosis 
(DKA). DKA typically occurs in patients with poor glycemic control secondary to 
nonadherence, acute illness or extreme stress. Basically, in the presence of a significant 
stressful event or an illness, hormones block the effects of insulin and cause the liver to 
release stored glucose. When the body does not have enough insulin, muscles are 
deprived of glucose and the body breaks down fat for energy, thus ketones (fat 
metabolite) are formed and can be identified in the urine. Although DKA is typically 
diagnosed in patients with type 1 DM. high glucose levels can lead to a potentially fatal 
condition (hyperglycemic hyperosmolar nonketotic syndrome) in patients with type 2 
DM.
Hyperglycemic hyperosmolar nonketotic syndrome (HHNS) is a condition that 
occurs exclusively in patients with type 2 DM. The diagnosis of HHNS is made when 
blood glucose levels increase to a range between 600 and 1000 (normal BG range = 70- 
120). The process leading to HHNS begins when blood glucose levels increase to a high 
level resulting in subsequent increased compensatory urine output. The process may 
continue for days or weeks and can eventually lead to severe dehydration. Extreme 
dehydration thus leads to confusion and consequent lack of ability to increase necessary 
fluid intake. Eventually, severe dehydration can lead to seizure, coma and death.
HHNS is typically the result of undiagnosed and/or poorly managed type 2 DM. At 
least one-third of all cases of HHNS are diagnosed in patients residing in nursing home 
placements. Stress, alcohol, untreated infection, diuretics, or even a stroke can
8
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contribute to the onset of HHNS (ADA, 1999). In addition to these potentially fatal 
acute conditions, DM can lead to long-term medical complications.
The longer the duration of DM, the greater the likelihood of developing DM- 
related medical complications (Shillitoe, 1988). Complications include degenerative 
changes in the micro and macro-vascular systems resulting in peripheral vascular 
disease, neuropathy, retinopathy and nephropathy (Kovar, Harris & Hadden, 1987).
DM is the leading cause of blindness, lower extremity amputations and kidney 
transplants in the United States (Cox & Gonder-Frederick, 1992). The risk for lower 
extremity amputation has been reported to be IS times greater in patients with DM than 
in nondiabetics. Diabetes has also been shown to have both transient and permanent 
neurocognitive sequelae, which have been associated with a variety of 
neuropsychological deficits (Holmes, 1990). As considerable brain development occurs 
throughout childhood and into adolescence, pediatric patients with diabetes are at 
elevated risk of neurocognitive impairment from this disease (Rovet & Fernandes, 
1999). Additionally, rates of periodontal disease, systemic and peripheral infection and 
digestive disease are significantly higher in patients with DM than in the general 
population, and largely account for the higher rates of disability and mortality 
associated with this medical illness (Lustman, Griffith, Freedland, Kissel, & Clouse, 
1998).
During the last decade, researchers have identified a group of risk factors for 
coronary heart disease which appear to commonly coexist: hyperinsulinemia, 
dyslipidemia, hypertension, and obesity. Coexistence of these cardiovascular risk 
variables has been termed insulin resistance syndrome (IRS) (DeFronzo & Ferrannini,
9
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1991), deadly quartet (Kaplan, 1989), and multiple metabolic syndrome (Liese, Mayer- 
Davis, & Haffner, 1998), but is most commonly referred to as Syndrome X (Reaven, 
1988). Up to 80% of patients with type 2 DM are estimated to have comorbid 
macrovascular risk factors (i.e., hypertension, hyperlipidemia, atherosclerosis) 
(Spanheimer. 2001). In the Framingham Heart Study, the primary incidence of coronary 
heart disease in patients with diabetes aged 45 to 74 years was more than two times 
greater in diabetic men and five times greater in diabetic women than in their non­
diabetic counterparts (Kannel, 1985).
Syndrome X has been documented in both children and adults, and is likely 
influenced by the age related progression of insulin resistance found in type 2 DM 
(Chen et al., 2000). The fundamental abnormality leading to the manifestations that 
comprise Syndrome X is resistance to insulin regulation of muscle glucose uptake and 
adipose tissue decomposition. Epidemiological evidence has documented insulin 
resistance as an independent risk factor for atherosclerosis, hypertension, 
hyperlipidemia and coronary heart disease.
Fortunately, recent evidence confirms that improved glucose control in both 
type 1 and type 2 DM can result in improved outcomes and decreased risk of 
complications (Diabetes Control and Complications Trial Research Group [DCCT], 
1996; United Kingdom Prospective Diabetes Study Group [UKPDS, 1998 a, b]). Thus, 
interventions aimed at regulating blood glucose and empirical research focusing on 
factors that mediate blood glucose fluctuations have very meaningful health 
implications (Goetsch, Abel & Pope, 1994).
10
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In summary, both types 1 and 2 DM are complex medical disorders 
characterized by abnormal glucose metabolism and high rates of comorbid cardiac risk 
factors. Both are associated with potentially lethal acute medical sequelae, as well as 
increased risk of long-term disabling consequences including cognitive impairment, loss 
of vision, kidney failure and amputation. Although the prevalence of DM has been 
documented to affect more Americans than breast cancer and HIV/AIDS, research 
dollars dedicated to identifying the etiological and epidemiological factors associated 
with this disease significantly lag behind that allocated to these other chronic illnesses 
(Davidson. 1998).
Epidemiological Aspects
Diabetes Mellitus is a major medical, personal and public health problem. Over 
10 million people in the United States are diagnosed with DM and estimates suggest 
that there may be another 5-6 million who are undiagnosed (Krein & Klamerus, 2000).
It is further estimated that 200 million persons worldwide are affected with DM (Harris,
1995). Unfortunately, the incidence and prevalence of DM continues to rise (Center for 
Disease Control and Prevention [CDC], 1997, 1999: ADA. 1999). Approximately 
1,800 new cases of DM are diagnosed each day, with approximately 657,000 new cases 
diagnosed each year (ADA. 1999). Additionally. DM is the seventh leading cause of 
death in the United States (CDC, 1999) and the second most common reason for patient 
contact with a physician (Janes, 1995). Each year approximately 130,000 deaths are 
directly attributable to the disease, while many other deaths are associated with DM- 
related complications (CDC, 1997).
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Apart from being a serious medical problem, DM represents a large economic 
burden on individuals and society. Diabetes is estimated to account for 15% of all 
health care expenditures in the U.S. (Harris, 1995). Nationally, the annual cost of DM 
has been estimated at $92 billion, with hospital costs responsible for approximately 
two-thirds of medical care expenditures (CDC, 1999). Substantial costs are incurred not 
only for direct costs of medical care for diabetes, but also for indirect costs, including 
lost productivity resulting from diabetes-related premature disability (Harris, 1995).
DM is the principal cause of new cases of blindness in working-aged adults; contributes 
to 50% of non-traumatic lower extremity amputations; is responsible for 35% of new 
cases of end-stage renal disease, and is associated with two to four times the increased 
risk for cardiovascular disease (Wingard & Barrett-Connor, 1995; Kuller, 1995).
Certain factors have been identified which increase the likelihood of developing DM.
DM has been associated with a number of identifiable risk factors including 
gender, age and ethnicity. Although men and women are equally predisposed to 
develop type 1 DM, women are more likely to develop type 2 DM (Harris, 1995). The 
age-associated risk of onset between the two diseases also varies. Although children are 
at greatest risk of developing type 1 DM (LaPorte et al., 1981), type 2 DM typically 
starts in adulthood and increases substantially as a function of age. Type 2 DM is 
estimated to effect approximately 26 per 1000 persons of all ages; however, this rate 
doubles for those ages 45 to 64 years, and it is estimated to effect one in 10 adults older 
than age 65. Further, it is reported that over 20% of those over the age of 80 years have 
DM (National Center for Health Statistics, 1988). While the prevalence of DM has
12
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remained fairly constant for White sub-populations during the last decade, rates for 
Non-White groups continue to rise.
Caucasians are slightly more likely than Non-White groups to develop type 1 
DM (ADA, 1999). However, for patients with type 2 DM, minority groups are 
particularly at risk. Harris (1995) found that Hispanic patients were three times as 
likely to develop type 2 DM in comparison to their non-Hispanic counterparts. 
Additionally, Native Americans are nearly 11 times more likely to develop the illness. 
Another group particularly vulnerable to DM is the African American population. It is 
estimated that the prevalence of type 2 DM among African-American individuals is 
approximately twice that of White persons (Tull & Roseman, 1995).
Although the prevalence of DM among Caucasians began leveling off in 1975 
(Butler. Segundy, & Romberg, 1994), disease incidence continues to increase among 
African Americans (National Center for Health Statistics. 1989). The age-adjusted 
incidence is approximately 50% higher in African American men than in White men, 
and more than twice as high in African American women than in White women (Ford, 
Tilley, & McDonald, 1998; Lipton, Liao, Cao, Cooper, & McGee 1993). Population 
studies indicate that one in four African American women age 55 and over have DM 
(Roseman. 1985). Additionally, the mortality rate for African Americans secondary to 
DM and its associated complications has been estimated at twice the rate for 
Caucasians. African Americans are at increased risk for the development of both 
lower-extremity amputations and kidney disease (Tun & Roseman, 1995). These data 
highlight the importance of identifying causal contributions to this observed racial 
discrepancy (Anderson-Loftin, 2000). Moreover, former President Clinton announced a
13
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public health initiative to eliminate the disparity in the incidence of DM and its 
complications in U.S. minority populations by the year 2010 ADA, 1999). 
Unfortunately, the African American population continues to be underrepresented in 
DM research (Anderson-Loftin, 2000).
Among African-Americans, the rising incidence of DM and the higher rates of 
mortality and morbidity have prompted researchers to examine salient variables for 
clues explaining the gap in health status between Caucasians and African Americans. 
One factor postulated as a possible contributing factor associated with the observed 
increased mortality rate among African Americans is the high rate of poverty in this 
community (Liu et al., 1982; Winkleby, Fortmann, & Barrett, 1990; Haan, Kaplan, & 
Camacho, 1987; McCord & Freeman. 1990). Approximately one-third of all African 
Americans are reported to live in poverty (U.S. Department of Health and Human 
Services, 2000). However, the racial discrepancy in mortality appears to extend beyond 
economic status. While controlling for family income, Sorlie, Rogot. Anderson, 
Johnson, and Backlund (1992) studied mortality rates in a representative sample of U.S. 
African Americans and Caucasians (National Institute of Health, 1992). Although 
greater income was associated with lower mortality rates for both genders and for both 
Black and White persons between the ages of 25 and 64, African Americans exhibited 
greater mortality than Caucasians at every level of income. Interestingly, the lowest 
income identified was among African American women, 51% of whom reported an 
income below $10,000 per year.
Lower socioeconomic status and being of African American origin are also risk 
factors for cardiovascular diseases associated with diabetes (Gaillard, Schuster,
14
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Bossetti, Green & Osei. 1997). In the United States, hypertension occurs more 
frequently among Black than White Americans with diabetes. It is further estimated 
that the prevalence of hypertension in Black adults with type 2 DM approaches 70%, 
and between 40% and 50% have diagnosed dyslipidemia (Tull & Roseman, 1995).
In conclusion. DM represents a major personal and economic health problem 
with an alarming rate of comorbid medical diseases. Several risk factors have been 
identified which place an individual at risk for developing DM and its complications 
including being a woman, being of low socioeconomic status and being of African 
American decent. Although diabetes is of public health importance for all ethnic 
groups, there is a need to address this problem specifically in the Black population.
Thus, the mission of the American Diabetes Association, "to prevent and cure diabetes 
and to improve the lives of all people affected", can only be met by targeting research 
efforts to those at highest risk (Davidson, 1998).
Etiological Aspects
Different etiological factors have been hypothesized to cause the onset of DM; 
however, no definitive theories have been documented. For both type 1 and type 2 DM, 
environmental factors acting in concert with predetermined genetic susceptibility are at 
the basis of most etiological assumptions. First, there is ample evidence to support the 
hypothesis that type 1 DM is caused by a combination of inherited and 
autoimmunologic processes that destroy the pancreatic beta cells. Beta cells are critical 
for life because they are responsible for the production of insulin, the hormone essential 
for glucose metabolism. Without insulin, glucose accumulates in the bloodstream as the 
body attempts to draw on other sources for energy until it eventually starves to death.
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Persons with genetic markers for human leukocyte antigens (HLA) are at increased risk 
for developing type I DM. However, many patients with type 1 DM have no known 
family history of the disease and, furthermore, only 20% to 50% of identical twins of 
those with type 1 DM develop the disease. Therefore, researchers have suggested 
several non-genetic factors which may account for the onset of type 1 DM including 
autoimmune processes.
There is evidence to support the hypothesis that type 2 DM is also caused by a 
combination of heritable and environmental processes. In twin studies, the rate of 
inheritance of type 2 DM is between 60% and 75% (ADA, 1999). Although research 
has not yet isolated a single gene responsible for type 2 DM, an inhibitor protein called 
PC-1 appears to be more prevalent in those with type 2 DM. PC-1 is purported to block 
the insulin receptor, thereby creating insulin resistance. Although genetics also appear 
to play a role in the development of type 2 DM, the most important trigger of type 2 
DM is obesity.
The prevalence of type 2 DM is increasing rapidly in the U.S. and industrialized 
nations for two reasons: the rate of obesity is rising and the population is aging. Obesity 
is not associated with type I DM; however, the association between obesity and type 2 
DM is impressive. It is estimated that between 60% and 90% of adults with type 2 DM 
are obese (Body Mass Index score > 28). Additionally, siblings of diabetic patients are 
three times as likely to develop DM when they are overweight, as compared to their 
non-obese siblings (Davidson, 1998). However, the observation that the development 
of DM is not uniform among obese subjects has led researchers to hypothesize other 
possible causal contributions.
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In Western industrialized countries it is estimated that approximately half of 
obese subjects develop DM, while in certain other ethnic groups (e.g., Native 
Americans), the incidence approaches 100%. Type 2 DM results when insulin 
resistance is insufficiently compensated by insulin secretion (Bjomtorp, Holm, & 
Rosmond, 1999). Insulin resistance is much more pronounced in pauents with c entral 
abdominal obesity than in those with primary peripheral obesity. Specifically, when 
excess adipose dssue is concentrated in the visceral (abdominal, central) fat stores, the 
risk for developing DM is higher than in peripheral gluteo-femoral obesity (Ohlsson et 
al., 1985; Bergstrom et al., 1990; Bjomtorp, 1993; Kissebah & Krakower, 1994). 
Bjomtorp (1997) hypothesized that the hypothalamic-pituitary-adrenal (HPA) axis 
appears to be hypersensitive to abdominal obesity. This results in a blunting 6 the 
feedback control mechanism by central glucocorticoid receptors, thus resulting in 
increased insulin resistance. Additionally, it has been suggested that insulin resistance 
may be an adaptive response to an overproduction of insulin (hyperinsulimia). In fact, 
the amount of excess body weight is related to the degree of hyperinsulimia (Davidson, 
1986). Fortunately, substantial evidence now suggests that glucose tolerance can return 
to normal with weight loss in many patients with type 2 DM (ADA, 1999).
The demographic, genetic and environmental risk factors associated with the 
development of DM have been extensively studied, but psychological aspects have not 
been well characterized. The role of psychosocial factors in the etiology of type 1 DM 
has long been a controversial topic. Investigators at one extreme hypothesize that 
psychosocial factors play a causal role in the onset of the illness. For example, 
McClelland, Patel, Brown, and Kelner (1991) found that type 1 diabetic patients who
17
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
had recently experienced the loss of a loved one showed an increase in T-cell count 
(secondary to an autoimmune response) when reminded of the loss compared with 
subjects suffering from other diseases. Theoretically, this stress-induced heightened 
immune response is related to the autoimmune deficiency seen in type 1 DM.
However, there is little additional empirical evidence that psychological factors 
contribute to the development of type 1 DM.
Contradictory findings have been reported about the role of emotional variables 
in the etiology of type 2 DM. Surwit and Feinglos (1988) speculate that the central 
nervous system, by way of various interactions between stress and the autonomic 
nervous system, may be involved in the development and course of type 2 DM. A 
variety of abnormalities in sympathetic nervous system activity have been documented 
in patients with type 2 DM including an exaggerated suppression of insulin secretion 
and profound hyperglycemia in response to epinephrine (i.e., stress response).
Although no definitive psychological factors have been identified as etiological 
variables, DM remains one of the most psychologically and behaviorally demanding of 
the chronic medical illnesses. Adequate management of diabetes requires satisfactory 
performance of a number of behavioral activities necessitating extensive disease self­
management. However, one of the frustrating ironies of DM is that efforts to keep 
blood sugar under good control (e.g., insulin administration, diet control) increase the 
risk of overcompensation resulting in potentially lethal episodes of hypoglycemia. 
Perhaps most important from a psychological and behavioral perspective, patients must 
adhere to the demanding requirements of DM management while knowing that eventual 
onset of complications is almost inevitable (DCCT, 1993).
18
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Behavioral Risk Factors
Padents following a DM regimen are faced with several unique psychological 
and behavioral challenges. The DM regimen typically involves multiple daily 
behavioral tasks (i.e., self-monitoring of blood glucose, foot care) as well as changes in 
basic lifestyle habits (i.e., diet, exercise), all of which must be performed for the 
duration of the patient's life. Treatment advances and disease progression also require 
the patient to be involved in continuing education and ongoing modifications in 
treatment regimens.
Fortunately, close adherence to recommended self-care activities can 
significantly lower the risk of associated diabetes-related complications. Of far- 
reaching importance is the recently concluded Diabetes Control and Complications 
Trial (DCCT, 1993). This 29-center, prospective, controlled clinical trial demonstrated 
the beneficial effect of intensive DM treatment (BG < 120) on retinopathy, 
nephropathy, and neuropathy in patients with type 1 DM. The newly completed United 
Kingdom Prospective Diabetes Study (UKPDS, 1998a) found similar results in patients 
with type 2 DM (Ohkubo et al., 1995). For twenty years, over 5,000 participants with 
type 2 DM were enrolled in the UKPDS. The results reveal that patients with type 2 
DM who maintain tight glycemic control experience fewer microvascular 
complications. Additionally, if blood pressure remains in good control, patients can 
significantly reduce their risk of virtually all cardiovascular complications. Together, 
these important findings suggest that patients can minimize the potential complications 
of DM if adequate glycemic control is achieved and maintained. Unfortunately, many 
patients with DM do not adhere to their medical regimen.
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The impact of non-adherence with recommended treatment regimens on health 
status is staggering (Leese, 1992). Wing, Norwalk, Marcus, Koeske, and Finegold 
(1986) reported that rates of non-adherence to health regimens among patients with 
diabetes range from 33% to 75%. Diabetes non-adherence can manifest in multiple 
areas including inconsistent self-monitoring of blood glucose, poor medication 
compliance, deficient dietary intake and irregular attendance to medical appointments. 
Given the complex nature of the disease and the variable capacity of patients to cope 
with its treatment requirements on a daily basis, it is not surprising that widespread 
individual differences exist in psychosocial adaptation to diabetes. Therefore, recent 
interest in the role of psychological factors in compliance has become an important 
research topic.
Under the influence of theoretical models such as the Health Belief Model 
(Rosenstock, 1974) and Social Cognitive Theory (Bandura, 1986), researchers have 
attempted to identify psychosocial factors related to self-care behaviors. In a recent 
review article, Glasgow (1995) concluded that among the most consistent variables 
associated with regimen adherence and self-care behaviors are environmental influences 
such as social and family support (Glasgow and Toobert, 1988; Littlefield, Rodin, 
Murray & Craven, 1990; Sherboume, Hays, Ordway, Dimatteo, & Kravitz, 1992). 
Fisher et al. (2000) reviewed the literature regarding factors known to affect self-care 
practices for patients with type 2 DM. They suggest that, over time, the characteristics 
of the patient's family, which is the primary social context of disease management, may 
account for the most variance in adherence rates. Several reasons exist for devoting 
more attention to the family regarding clinical management of type 2 DM.
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First, most disease management behavior is sanctioned by, or takes place within 
the family setting. Second, the family embodies the patient's most powerful and 
influential web of intimate personal relationships and can have an enormous supportive 
or deleterious effect on patient behavior, health and well-being (Rolland, 1994). Third, 
what is often interpreted as exclusive patient self-care behavior is often the result of 
combinations of patient and spouse behavior or spouse behavior alone (i.e. food 
preparation, exercise monitoring, health monitoring) (Fisher et al., 2000). Thus, from a 
clinical perspective the patient's social environment may be an important place to target 
treatment intervention (Anderson. 1990).
In summary, patients following a DM treatment regimen are faced with several 
behavioral challenges. However, maintaining adequate glycemic control can 
significantly lower risks for associated long-term complications. Therefore, factors 
contributing to adherence (i.e., family support system) are currently of considerable 
policy and research interest. Recent attention has been given to the role of comorbid 
psychopathology in disease management. The unique importance of the management of 
psychopathology in medically ill populations (e.g.. diabetes) may be its potential to 
indirectly improve the medical condition itself by increasing self-management efforts.
Psychopathology in Primary Care 
The past decade of research has seen a proliferation of studies investigating the 
comorbidity of mental and physical illness. Epidemiological studies suggest that the 
prevalence of anxiety and depressive disorders in primary care settings range from 10% 
to 30% (Perez-Stable, Miranda, Munoz & Ying, 1990; Schulberg & Bums, 1988; 
Jenkins, 1995; Kirmayer. Robbins, Dwoerkind, & Yaffe, 1993). Katon (1982) found
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that more than 33% of consecutive primary care attendees reported substantial levels of 
psychological distress, with approximately 15% to 25% meeting diagnostic criteria for 
an affective disorder. Currently, there is little doubt that affective disorders are highly 
prevalent in primary care and have untoward effects on patient health outcomes.
The high prevalence rate of psychiatric symptoms among primary care 
populations is of considerable clinical and policy interest for several reasons. First, 
psychiatric disorders complicate the clinical assessment of patients with chronic 
medical disease and vice versa. Second, primary care physicians may not always detect 
affective disorders in patients with medical disease. Third, treatments for the two types 
of disorders may interact and/or conflict. Fourth, coexisting affective disorders can 
increase the utilization rate of both medical and psychiatric health care services. Lastly, 
comorbid affective disorders may increase the disability of persons with chronic 
medical conditions (Wells, Rogers, Bumam & Camp, 1993). Whether occurring 
independently or comorbidly, anxiety and depression are the two most commonly 
encountered psychiatric problems in medically ill patients (Katon, 1982).
Depression in the Primary Care Setting
Depression is a major public health problem, with a clinical diagnosis affecting 
approximately 5% of the population (Myers et al., 1984; Robins et al., 1984). 
Specifically, approximately 2.3% to 3.2 % of men and 4.5% to 9.3% of women are 
believed to suffer from a current episode of depressive illness (American Psychiatric 
Association [APA], 1994). However, the prevalence of depressive disorders in the 
primary care sector is even greater. Results of multiple primary care studies indicate 
that an alarming 30% of patients seen by primary care physicians suffer from a
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depressive disorder (Kessler, Cleary, & Burke, 1985; Ruckler, Frye, & Cygan, 1986; 
Katon and Schulberg, 1992; Regier et al., 1993; Brantley, Mehan & Thomas, 2000). 
Moreover, approximately 50% of all patients who are treated for depressive illnesses 
are seen exclusively in primary care clinics. Considerable research over the. last decade 
has clearly demonstrated the burden that depressive illnesses have on individuals and 
society as a whole (Simon, Von Korff, & Barlow, 1995).
Depression has been shown to produce profound social and vocational disability 
(Schulberg et al., 1997). The Rand Medical Outcomes Study (MOS) (Wells, Stewart et 
al., 1989) concluded that the debilitating effects of depression equal or surpass those of 
many chronic physical illnesses, including arthritis, heart disease and low back pain. 
Additionally, a diagnosis of depression is associated with an increased frequency of 
health care visits and associated health care costs (Simon et al., 1995). Simon et al. 
reported that patients diagnosed with depression had higher annual health care costs 
($4,246 vs. $2,371, pc.OO 1) than patients without a depressive diagnosis. The high 
prevalence rates and significant negative ramifications of depressive symptoms among 
primary care populations underscore the importance of identifying potential causal 
variables (Brantley et al., 2000).
Several hypotheses have been suggested to account for the elevated rates of 
depression in those with chronic illness including the distress associated with restricted 
physical activity and unfulfilled role obligations (Cohen & Lazarus, 1979; Wells. 
Golding, & Burnham, 1989); the unpredictable or uncontrollable course of illness 
symptoms (Smith, Peck, & Ward, 1990); the burden of disease management 
requirements (Connell. 1990); the disturbance in social activities (Connell, Fisher, &
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Houston, 1992); and the impact of illness on quality of life, self esteem and morale 
(Connell, 1990; Connell, Storandt, & Lichty, 1991).
Although multiple studies have been conducted to evaluate rates of depression 
in primary care populations (Von Korff et al., 1987; Spitzer, Williams & Kroenke,
1994; 1995; Katon and Rove Byrne, 1989), less is known about the extent to which 
anxiety disorders and chronic medical illnesses co-occur (Broadhead, Blazer, George, & 
Tse, 1990). It has been hypothesized that research in primary care settings has not 
focused as much on anxiety disorders, especially GAD, because these problems are 
often seen as neuroses or transient reactions to stress rather than as psychiatric illnesses 
warranting clinical attention (Rickels & Schweizer, 1990). However, Zung, Broadhead 
and Roth (1993) identified that among the top 25 most common reasons for patients to 
seek medical attention, depression ranked 24th, and anxiety ranked 25th. Additionally, 
using data from the 1991 National Ambulatory Medical Care Survey, Schappert (1994) 
reported that 33.6% of patients with a psychiatric diagnosis who go to primary care 
providers list anxiety as the first reason for seeking medical attention. Therefore, it 
appears that anxiety in the primary care setting is a significant issue.
Anxietv in the Primary Care Setting
While fewer studies have examined anxiety in the U.S. primary care population 
as compared to depression (Fifer et al., 1994), epidemiological studies in the general 
population have reported anxiety symptoms and disorders at prevalence rates of 6.6% to 
14.9% (Myers et al.. 1984). According to the 1980-1984 Epidemiologic Catchment 
Area Study (Regier et al., 1988), anxiety disorders have a one-month prevalence rate in 
the U.S. of 7.3%. From 1990 to 1992, the National Comorbidity Study (Kessler et al.,
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1994) identified that over a 12 month period, 1.3% of those aged 15 to 54 years met 
criteria for a DSM-DI-R diagnosis of panic disorder, 2.8% for agoraphobia, 7.9% for 
social phobia and 3.1% for GAD. However, Orleans, George, Houpt & Brodie (1985) 
concluded that the incidence in primary care patients is significantly higher. They 
concluded that the incidence of a current anxiety disorder can be expected in 15% to 
18% of primary care patients; and lifetime prevalence rates are estimated at 26% to 
28%. These data support the contention that anxiety disorders are among the most 
common mental health problems (Regier et al., 1988). Additionally, anxiety disorders 
tend to be chronic conditions that may persist for many years (Taylor & Gorman, 1992; 
Brown, Rakel, Wells, Downs, & Akiskal, 1991) and can significantly impact 
employment and functional ability.
Anxiety disorders have also been associated with higher rates of other comorbid 
psychopathology, increased disability and poorer health outcomes. Much of the 
literature on the concurrence of anxiety disorders with other psychiatric conditions has 
focused on depression. In general, the odds of having an anxiety disorder if one also 
has Major Depressive Disorder (MDD) are nine to 19 times higher than in those who 
are not depressed (Body, Burke & Gruenberg, 1984). It is further estimated that 
approximately 35% to 60% of patients with depressive disorders also have significant 
anxiety symptoms (Roy-Byme & Katon, 1997; Lydiard, 1991). Therefore, it appears 
that the comorbidity of anxiety and depression occurs in a significant percentage of 
patients.
Anxiety disorders have also been associated with increased utilization rates and 
worsened psychiatric and medical disease outcomes (Lustman, Griffith & Clouse,
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1988). When anxiety disorders occur in combination with other serious psychiatric and 
medical illnesses, results include increased morbidity and service utilization, decreased 
quality of life, and substantial social costs (i.e., increased rates of unemployment, 
financial dependency) (Sherboume, Wells, Jackson, Meredith, Camp, 1996; Schonfeld 
etal., 1997).
In summary, both depression and anxiety disorders are highly prevalent among 
patients attending primary care clinics. Additionally, both are associated with 
functional disability, increased health care costs and decreased medical adherence. It is 
further estimated that the two conditions occur concurrently in a majority of patients. 
The substantial differences in the quality of life between medically ill patients with and 
without anxiety and depressive disorders highlight the importance of identifying these 
affective disorders among primary care patients. Specifically, identifying and treating 
anxiety and depressive disorders in patients with DM may have important disease 
management implications.
Psychopathology and Diabetes Mellitus
Although DM has been described as a "hidden handicap" in that, when it is
under control, there is no external evidence of the disease, sufferers of this life-long 
*
illness have been widely reported to be at risk of developing emotional disorders 
(Akinlade. Ohaeri & Suberu, 1996). In the last decade, interest in psychosocial factors 
in DM has increased (Berlin et al.. 1997) and evidence suggesting that psychiatric 
disorders are more prevalent among adults with DM is mounting (Lustman et al., 1986; 
Popkin et al., 1988). However, whether these conditions are caused by, or result from, 
the diabetic disease remains unknown.
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Diabetes Mellitus has been associated with a greater prevalence of psychiatric 
disorders of mild to moderate severity than expected in the general population (Mayou, 
Peveler, Davies. Mann, & Fairbum, 1991; Lustman, Skor, & Carney 1983; Wells, 
Golding & Burnham, 1988b; Wilkinson et al., 1988; Weyerer et al., 1989). Psychiatric 
disturbance has also been associated with poor compliance with DM treatment, poorer 
glycemic control and thus, an increased risk for diabetes-related complications 
(Lustman et al., 1998). Additionally, patients with DM have been reported to use more 
psychotropic drugs (Isacson & Stalhammar, 1987), psychiatric hospital days and more 
outpatient mental health services (Mayou et al., 1991) than non-diabetics. Comorbid 
psychopathology has also been associated with elevated medical risks and impaired 
quality of life in patients with DM (Helz & Templeton, 1990; Sherboume et al., 1996).
Psychiatric disorders have been reported to be more common among sub-groups 
of diabetics. For instance, those with increased medical complications (Wulsin, 
Jacobson & Rand 1987). hospital admissions for poor glycemic control (Wrigley & 
Mayou, 1991), and those with “brittle" DM (Pickup, 1985; Tattersail, 1985). Such 
observations have led researchers to speculate that psychiatric disorders in persons with 
DM may have an organic etiology associated with the metabolic abnormalities 
associated with DM (Lustman, Amado, & Wetzel. 1983; Popkin et al., 1988). In 
contrast, others have postulated that DM may be causally independent of emotional 
factors, the apparent association being related to behavioral factors including the 
influence of psychiatric conditions on adherence to the DM management regimen 
(Lustman, Clouse & Carney, 1988).
27
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Given the many psychosocial aspects associated with the management of DM, it 
might be expected that these patients would be predisposed to emotional symptoms. 
These factors include the extensive self-care demands required for successful disease 
management, the burden which adherence to treatment may have on many aspects of 
everyday life, the financial liability associated with disease management (i.e., 
medication, glucose meter, strips, time away from work), and the possibility of long­
term physical disabilities resulting from the disease.
Depression and DM
It has been proposed that depression among individuals with DM may be 
reactive in nature, occurring in response to psychosocial hardships (e.g., physical 
disability, dietary restriction) related to their illness (Lustman et al., 1983). However, 
others have proposed that depressive symptoms among patients with DM may be 
organic in origin, caused by metabolic changes associated with DM (Popkin et al.,
1988: Lustman et al., 1986; Grandinetti et al. 2000). For example, hyperglycemia has 
been associated with increased plasma cortisol concentrations, which have been 
reported to precipitate mood changes in some patients with DM (Cameron, Kronfel. 
Greden, & Carroll, 1984). Furthermore, DM may be associated with higher rates of 
depression than other diseases because, unlike other diseases, DM is a significant risk 
factor for a number of other debilitating and potentially fatal conditions (i.e., Syndrome 
X). These theories suggest that DM carries a special risk for psychological disturbance, 
beyond that attributable to chronic disease in general.
A comprehensive Literature review undertaken by Gavard et al. (1993) found a 
significantly increased prevalence of depression in diabetic samples when compared
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with non-diabetic samples in 8 of 9 studies. The range for the prevalence of current 
depressive disorder obtained from structured diagnostic interviews in diabetic samples 
was 8.5% to 27.3%. Although these rates are at least three times the prevalence of 
MDD found in the general adult population of the U.S., they are much less than that 
published by other investigators when using depression symptom scales (i.e., 21.8% to 
46%) (Tun. Perlmuter. Russo. Nathan, 1987: Friis & Nanjundappa, 1986).
There is now evidence from several cross-sectional studies that comorbid 
depression is associated with poor glycemic control (Lustman et al.. 1986; de Groot, 
Jacobson & Samson, 1994). Additionally, the influence of poor glycemic control to the 
subsequent development and progression of DM complications is well established 
(DCCT. 1993). Thus, it is logical to assume thi-t the poor glycemic control seen in 
depressed diabetic patients would place these persons at increased risk of developing 
diabetic complications. Surprisingly, prior studies have not found an association 
between complications and depression in diabetic patients (Cohen, 1988). Lustman. 
Clouse and Carney (1988) reported that the occurrence of depressive episodes appeared 
independent of DM complications. They identified similar rates of complications (i.e. 
nephropathy, neuropathy, and retinopathy) in both depressed and nondepressed diabetic 
groups. They also suggested that depression is not directly related to advancing diabetic 
disease, as there were no significant differences at baseline and at 5-vear follow-up in 
the prevalence rates of DM complications between the two groups.
Despite numerous studies reporting a high prevalence of clinical depression and 
depressive symptoms among diabetic patients (Murawski, Chazen, Balodimos, 1970; 
Sanders, Mills & Martin, 1975; Lustman et al., 1986; Popkin et al., 1988; Wilkinson et
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al., 1988; Weyerer et al., 1989; Wing et al., 1990), evidence of a relationship between 
DM and depression remains inconclusive. For instance, the results of some studies fail 
to support the existence of this relationship (Robinson et al., 1988; Wells et al., 1988b). 
Additionally, several studies have found that while medical conditions in c eral are a 
risk factor for psychological disturbance, DM carries no special risk (Nielson & 
Williams, 1980; Turner & Noh, 1988; Bennett, 1994). Thus, suggesting that factors 
involved in the general burden of chronic illness contribute to the disturbance in 
affective state (Carney, 1998).
Two studies to date (Weyerer et al., 1989; Wells et al., 1988b) have compared 
rates of depression between people with DM and those with other medical conditions. 
The community interview study by Weyerer et al. (1989) found an increased, although 
nonsignificant, prevalence of current depression in diabetic individuals (27.3%) 
compared with individuals with another somatic illness (20.3%). The prevalence of 
any psychiatric disorder of any severity other than depression was virtually identical 
between diabetic individuals (15.8%) and healthy control subjects (15.6%). but was 
twice as high in those with other somatic diseases (30.4%). These findings indicate that 
DM may have a special propensity for depression and not for other psychiatric illnesses 
and that people with DM may be not be at higher risk than those with other somatic 
diseases.
Although neither Weyerer et al. (1989) nor Wells et al. (1988b) found a 
significant difference between the groups, they did not control for socioeconomic status 
or concomitant medical illness. Additionally, both studies reported a relatively low 
response rate (68%) and neither study verified the presence of DM by physician report.
30
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
The latter could have been a potentially serious limitation, as 26% of subjects may not 
have had a diagnosable diabetic condition (Wells et al., 1989).
Unfortunately, although many studies have been conducted, the conclusions that 
may be drawn from the existing epidemiological studies examining the prevalence of 
psychopathology in DM are limited by methodological problems. Most prior studies 
have been based on biased samples, such as those referred for psychiatric evaluation or 
patients with particular physical complications (Surridge et al., 1984; Lustman et al.. 
1986; Robinson et al., 1988; Wilkinson et al., 1988; Tallroth, Karlson, Nilsson & 
Agardh. 1989; Wrigley & Mayou, 1991). Response rates have been low, and study 
populations have frequently been heterogeneous with regard to age. type of DM and 
mode of treatment. Thus, it has not been possible to obtain reliable estimates of the 
prevalence in subsamples, including those known to have different levels of 
psychological disturbance in the general population (e.g., gender, age, race, SES). For 
instance, gender has consistently been found to be a risk factor for psychological 
disturbance in diabetic patients, with women twice as likely to be depressed as men. 
Peyrot and Rubin (1997) found that both depression and anxiety were more prevalent in 
unmarried, middle-aged women with fewer years of education and more diabetic 
complications. Low socioeconomic status has been found to be associated with 
depression (Freichs, Aneshensel & Clark. 1981; Comstock & Kelsing, 1976).
Education is strongly associated with psychological disturbance, with college graduates 
experiencing less than half the risk of those who did not graduate from high school. 
Additionally, few studies have used the best available methods of psychiatric diagnostic 
assessment.
31
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Although self-report measures may be used as a crude criterion for the 
possibility of diagnosable psychopathology, they have been found to have high rates of 
false positives and thus, low positive-predictive power for diagnosis. Additionally, a 
major limitation in their use is that it cannot be assumed that similar psychological 
phenomena are being measured in the diabetic populations. Somatic symptoms of 
depression and anxiety (e.g., tiredness, loss of libido, concentration impairment and 
sleep and appetite disturbance) which are generally indicative of affective disturbance 
in the general population and psychiatric patients, may be related to the acute and 
chronic complications of the underlying glycemic imbalance in patients with DM 
(Meadows et al., 1996)
Perhaps the most important limitation of prior studies is the observation that, 
although an estimated 80% of diabetic men and women have type 2 DM, this group has 
virtually been ignored. Prior studies have predominantly focused on patients with type 
1 DM (Murawski et al., 1970; Sanders et al., 1975; Popkin et al., 1988; Wilkinson et al., 
1988; Kronfel, Greden & Carol, 1981; Lustman et al., 1983), or have included 
individuals with both types 1 and 2 DM, but failed to report on the two groups 
separately (Weyerer et al., 1989; Robinson et al., 1988; Friis & Nanjundappa, 1986). 
Given the different etiological basis and the varied treatment regimens associated with 
type I and type 2 DM, it might be assumed that the prevalence and manifestation of 
psychopathology would also vary. Although few prior studies have limited their sample 
to patients with type 2 DM, there is evidence that these patients may be particularly 
vulnerable to stress and comorbid psychopathology given the late age of disease onset 
and the significant life-style change requirements (Surwit & Feinglos, 1988).
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Eaton, Armenian, Gallo, Pratt, and Ford (1996) examined the prevalence of a 
diagnosis of a depressive disorder based on the DSM-IH-Revised (APA, 1980) in 
patients with type 2 DM. They found that MDD. but not milder forms of depression or 
other psychiatric disorders predicted the onset of DM even after controlling for age, 
race, gender, SES, education and BMI. However, a major limitation of this work is the 
use of self-reported diagnosis of DM. Therefore, the problem of undetected DM limits 
the generalizability of these findings, especially in light of a recent estimate that as 
many as 50% of type 2 DM who would be diagnosed by hemoglobin assay do not report 
having the illness (Harris. 1995).
Although an increased prevalence of depression in DM relative to the general 
population is highly suggested by the literature, biases and methodological problems 
commonly encountered in prevalence studies may interfere with the strength of this 
conclusion. Whether an increased association exists between DM and the depressive 
disorders remains controversial, despite an abundant body of literature dedicated to this 
issue (Carney, 1998). There is clear need for studies that provide accurate estimates of 
diagnosable psychiatric disturbance rates as several recent hypotheses concerning 
higher rates of comorbid psychopathology among people with DM postulate disease 
factors as mediating or causal factors (e.g.. elevated HPA activity).
Anxiety and DM
Although the last decade has seen a proliferation of interest in the area of 
psychosocial factors in DM (Berlin et al., 1997), few studies have focused on comorbid 
anxiety disorders. A review of the literature reveals that a variety of anxiety symptoms 
have been associated with both types 1 and 2 DM. Anxiety symptoms may be directly
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related to the management requirements of the diabetic condition. Specifically, in 
patients with type 1 DM, obsessional attempts at glycemic control may result in further 
problems. Beer. Lawson, and Watkins (1989) reported that the fear of low blood sugar 
is very common amongst patients who have had frightening or embarrassing 
experiences with hypoglycemic episodes. Such patients may monitor their blood 
glucose levels many times per day and tend to over-respond to the results, leading to 
erratic control and frequent hypoglycemic events. On the other hand, Tattersal,
Gregory, Selby, Kerr, and Heller (1991) coined the term "compulsive aglycosuria" to 
describe pauents who attempt to maintain low blood glucose levels ("run themselves 
low ") secondary to a great fear of hyperglycemia and its related complications. Hence, 
these patients also increase their risk of dangerous hypoglycemic episodes.
Additionally, in a survey by Mollema, Snoek & Heine (1996), 4% of diabetic patients 
reported suffering from the fear of self-injecting insulin or self-monitoring blood 
glucose. Furthermore, fear of diabetes-related complications, including blindness and 
amputations, may cause considerable anxiety for many patients.
Pevrot and Rubin (1997) used the Zung Anxiety Scale (Zung, 1975) to identify 
rates of anxiety symptoms among adults with DM and to identify factors associated 
with increased risk. They reported that approximately 50% of their sample had 
significant comorbid anxiety symptoms. Only two studies to date have utilized gold 
standard, structured psychiatric interviews to ascertain the prevalence of anxiety 
disorders in adults with diabetes. Lustman et al. (1986) included patients with both 
types 1 and 2 DM. They found that GAD was present in an alarming 52.8% of patients. 
Furthermore, 26.3% of their sample was diagnosed with simple phobia; 15.8% with
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agoraphobia, 10.5% with social phobia, 3.5% with panic disorder; and .9% with 
obsessive-compulsive disorder. Popkin et al. (1988) reported a prevalence rate of GAD 
to be approximately six times greater in patients with type 1 DM than in the general 
population. Considering the high rate of anxiety symptoms found in people with DM 
compared to the general population (Mayou et al., 1991), increased studies are needed 
to examine mediating and moderating variables so that effective interventions may be 
identified.
In summary, prevalence estimates of depressive and anxiety symptoms in 
patients with diabetes range from 20% to 50%; however, numerous methodological 
problems interfere with the strength of this conclusion. Spurious estimates could have 
resulted if the diabetic and control samples differed significantly on variables known to 
be associated with an increased risk of psychopathology (i.e.. gender, lower SES). 
Additionally, prior prevalence estimates have primarily relied upon self-report measures 
to determine both the presence of DM and psychological disorders in patients with type 
1 DM or combined samples of types 1 and 2 DM. Therefore, an increased prevalence 
of anxiety and depressive disorders in patients with documented type 2 DM relative to 
other somatic illnesses remains unproven.
Social Support
The past three decades have witnessed a number of studies investigating the 
relationship between coping mechanisms and the occurrence of both physical and 
psychological symptoms. One particular factor receiving attention is social support 
(Cobb, 1976; 1979; Gore, 1978; Henderson, 1981; Parry & Shapiro, 1986). Because of
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the intuitive nature of the construct, dozens of conceptual definitions of social support 
have been offered.
Caplan (1974) first suggested that a social support system provides information 
and cognitive guidance, tangible resources and aid, and emotional sustenance in times 
of need. Cobb (1976) provided an alternate definition of social support, which excluded 
tangible aid and resources. Cobb initially defined social support as “information 
leading the subject to believe that he is cared for and loved, esteemed and a member of 
a network of mutual obligation" (p.300). Later. Cobb (1979) offered descriptions of 
three additional forms of support: instrumental, active and material support. While 
social support has been variously defined. House's (1981) conceptualization has been 
most widely used in the literature.
House (1981) and later. Cohen and Wills (1985) suggest that social support 
consists of interpersonal transactions involving one or more of the following: emotional 
concern (i.e., expressions of liking, admiration, respect, love): instrumental aid or 
tangible assistance (i.e.. the use of relationships as a means to achieve a goal, provide 
money, labor or time, modify the physical environment for others): informational aid 
(i.e.. providing advice, suggestions, directives, information), and appraisal (i.e.. 
information relevant to self-evaluation).
It is hypothesized that social support functions in a stressor-specific fashion. 
Rabkin and Struening (1976) developed a stressor-illness model, proposing that 
vulnerability to stress may be mediated ly such factors as biological differences, 
psychological characteristics and social support. Stressors differ in the type of 
adaptational demands they require. Social support systems differ with respect to the
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type of stress they can moderate. Thus, social support is effective in minimizing the 
negative effects of stress only when there is congruence between the adaptational 
demands of the stressor and the type of social support resources available. Thus, the link 
between social support and health has relied heavily on the work of Lazarus and 
colleagues.
Social Support and Stress
According to Lazarus and Folkman (1984), management of a chronic medical 
illness can be seen as a stressful life circumstance, which can subsequently influence 
both medical and mental health. However, it is the function of psychological factors 
(i.e. cognitive appraisal), to determine whether a particular life event is considered to be 
stressful. According to Lazarus and Folkman, people experience psychological distress 
when they confront a situation that requires some form of adaptation that exceeds their 
perceived capabilities. Therefore, the cognitive appraisal of a stressor plays a central 
role in the stress and coping process.
The cognitive appraisal process has been divided into two stages: primary 
(event) appraisal and secondary (resource) appraisal. Primary appraisal involves 
evaluating the degree of stress associated with the environmental event. This typically 
involves an appraisal of whether the stressful event involves threat, harm, loss, and/or 
other challenge. Secondary appraisal involves the evaluation of one's coping repertoire 
or resources. This is the stage in the stress and coping process during which social 
support plays its major role (Cohen & McCay, 1985).
Prior researchers have identified two potentially coexisting models to explain 
the variability in the impact of social support as a coping resource. The direct-effect
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model assumes that social support has a beneficial effect on psychological health 
regardless of whether stress (e.g., due to illness) is present (Broadhead et al., 1983; 
Cassel, 1976). According to the buffering model, social support may mitigate the 
negative influence of stress on physical and psychological health (Cobb, 1976; Cohen & 
Syme. 1985).
The stress-buffering hypothesis asserts that social support lessens the impact of 
stress on well-being, but does not affect emotional health in the absence of stress 
(Thoits. 1985). In other words, according to this hypothesis, high levels of stress 
predict emotional disruption in persons receiving low levels of social support but not in 
those receiving high levels of social support. An extensive literature base argues that 
people who have smaller social networks experience increased risk of negative health 
outcomes.
Social Support and Medical Illness
Substantial research has revealed that personal coping resources may contribute 
to the variable impact of chronic illness on psychological health and medical outcomes. 
Chronically ill patients who receive considerable social support have been found to be 
at decreased risk of developing a subsequent depression (Brown et al., 1986; Holahan & 
Holahan. 1987). Additionally, the importance of assessing social support is suggested 
by research linking high levels of social support to positive medical health outcomes 
(Cohen & Syme, 1985; Ornish, 1988; Cohen, 1988; Uchino, Cacioppo, & Kiecolt- 
Glaser, 1996). Substantial research has supported the hypothesis that social support 
contributes to the following; decreased susceptibility to disease and lower 
cardiovascular reactivity (Kamark, Manuch, & Jennings, 1990); enhanced immune
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function (Jemmott & Magliore, 1988; Kielcolt-Glaser et al., 1984); better adjustment to 
and recovery from illness (Dunkel-Schetter, 1984; Mumford, Schlesinger, & Glass, 
1982; Telawny-Ross & Russell. 1987; Wortman, 1984); and lower rates of mortality 
(Berkman & Syme, 1979; Blazer, 1982; House, Robbins & Metzer, 1982; Ruberman, 
Weinblatt, Goldberg, & Chaudhary (1984). Thus, the effectiveness of social support as 
a coping resource has been well established. Therefore, as quoted in Penninx et al.
(1998), "the question for future research is not whether coping resources are important, 
but to specify in more detail for whom...and under what circumstances various types of 
social support can be expected to influence health" (p.557).
As most previous studies have mainly been restricted to one specific illness 
group, it has not been possible to determine whether there is disease specificity in the 
effectiveness of social coping resources. However, there is indication for such disease 
specificity (Folkman & Lazarus, 1980; Penninx et al., 1996). For example, emotion- 
focused strategies are reported to be more effective in situations that are not amenable 
to individual control (Pearlin & Schooler, 1978). It follows that coping strategies 
addressing the emotional distress caused by a disease may be most successful in 
diseases that cannot be managed by individual or medical intervention. Specifically, in 
a life threatening disease (e.g., terminal cancer), emotional support from others (e.g., 
empathy) appears to protect against depression (Ell et al., 1989). Alternately, problem­
solving coping strategies have been reported to be most effective in situations more 
amenable to intervention. Therefore, in functionally disabled patients (i.e., those with 
DM), instrumental or tangible social support may be an important determinant of 
depression (Fitzpatrick et al., 1991). In sum, as chronic diseases have different
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characteristics regarding prognosis, extent of functional incapacitation and amenability 
to treatment, the function of social support resources may also differ. This argument 
may be especially germane to diabetes, due to the great variability in symptoms, 
complications, and adaptations to self-management demands that have been reported 
among various samples (Connell et al., 1994).
Social Support and DM
A review of the literature reveals that social support has been associated with 
improved glycemic control, adherence to diabetic self-management regimens, and 
emotional well-being in both type 1 and type 2 DM. Anderson, Miller, Auslander, & 
Santiago (1981) found that increased family cohesion and decreased familial conflict 
led to improved metabolic control in adolescents with type 1 DM. Similarly, in a small 
study of adolescents, Orr, Golden. Myers, & Marrero (1983) identified social isolation 
as a contributing factor for poor metabolic control. Schafer, McCaul, & Glasgow 
(1986) demonstrated that higher levels of non-supportive family behaviors were related 
to reduced regimen adherence and poor glycemic control. In addition to family support, 
support from peers has also been shown to be an important contributor to the initial 
emotional adjustment to the diagnosis of DM (Vami, Babani, Wallander, Roe & Frasier,
1989).
Although less information is known about the effect of social support on 
patients with type 2 DM, the results of Griffith, Field and Lustman (1990) support the 
stress-buffering hypothesis for glycemic control. Specifically, they found that when life 
stress was high, subjects reporting higher social support satisfaction had significantly 
better glycemic control than subjects reporting lower social support. However, when
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stress was low, satisfaction with social support appeared inconsequential in terms of 
glucose regulation.
Several researchers have identified social support as a beneficial resource for 
health behavior change and adherence (Wierenga, 1994). Specifically, the strength of a 
patient's support system has been positively associated with an individual's compliance 
with diabetic regimens including diet, urinary and blood glucose testing, foot care, 
medication adherence and exercise (Lloyd, Wing, Orchard, & Becker. 1993; Nagasawa, 
Smith, & Barnes, 1990). Additionally, Ruggiero, Spirito, Bond, Coustan, and 
McGarvev (1990) found increased adherence to insulin administration to be associated 
with higher social support scores in women with gestational diabetes. Glasgow and 
Toobert (1988) found family support to be the strongest and most consistent predictor 
of adherence to treatment in padents with type 2 DM. Garay-Sevilla et al. (1995) 
concluded that adherence to medicadon and diet in padents with type 2 DM was 
strongly associated with social support in a group of Hispanic padents residing in 
Mexico. Most recendy, Anderson-Loftin (2000) reported that social support improved 
self-management in padents with type 2 DM and contributed to increasing posiuve 
lifestyle changes.
In current medical pracdce, virtually all padents with type 2 DM are advised to 
make life-style changes, such as ingesdng fewer calories, exercising more, and adhering 
to a regimen of insulin and/or oral hypoglycemic agents (Kaplan & Toshima, 1985). 
Because the onset of type 2 DM is typically in the fifth decade of life or later, changing 
one's life-style is often difficult. The role of social relationships in the achievement of 
life-style change is, therefore, of considerable theoretical and practical importance.
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Thus, a great deal of empirical research conducted with samples of individuals with DM 
has focused on predictors of regimen adherence, self-care behavior and metabolic 
control. Although these outcomes are important, more recent attention has been 
afforded to psychosocial adaptation to DM (Connell et al., 1994).
Social support has been identified as an important contributor to emotional 
health among persons with DM (Connell et al., 1994; Bailey, 1996; Connell et al, 1992; 
White, Richter, & Fry, 1992; Littlefield et al., 1990). Unfortunately, prior research 
addressing psychological factors among individuals with DM has rarely been informed 
by a theoretically driven model (Connell et al., 1994). In one exception. Littlefield et al. 
(1990) tested the buffering model of social support on the incidence of depression 
among 158 adults with both type 1 and type 2 DM. They found that individuals 
reporting lower social support and high levels of illness-related disability were at 
highest risk for depression. Although this research made an important contribution to 
the literature, demographic and other background characteristics were not included in 
the tested model. Additionally, the generalizability of these findings is limited by the 
use of a self-reported screening instrument to establish the presence of depression. 
Additionally, although depressive symptoms have been negatively correlated with 
increased social support, the literature does not consistently support this association.
Connell et al. (1991) found that although diabetes-specific social support was 
highly predictive of self-care behaviors, it was not correlated with depression among 
older adults. Later, Connell et al. (1994) found that diabetes-specific social support was 
not a significant predictor of elevated Center for Epidemiologic Studies Depression
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scale (CES-D) (Radio ff, 1977) scores in community dwelling adults with type 1 and 
type 2 DM.
In summary, although it has been repeatedly demonstrated that social support is 
a beneficial resource for diabetic glycemic control, health behavior change and 
adherence, very little is known about the impact of social support as a moderating 
variable in the incidence of affective disorders in patients with DM. Thus, this study 
contributes to the literature by investigating the direct and moderating effects of social 
support in the association of depressive and anxiety disorders in patients with type 2 
DM.
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PURPOSE OF STUDY 
Summary
Approximately 16 million Americans or 6% of the U.S. population are living 
with Diabetes Mellitus and unfortunately, the incidence continues to increase. Apart 
from being a serious medical problem, DM represents a large economic burden on 
individuals and society. Each year approximately 130,000 deaths are directly 
attributable to the disease, while many other deaths are associated with DM-related 
complications. It is further estimated that the prevalence of DM among African- 
American individuals is approximately twice that of White persons. Additionally, 
women and the socioeconomically disadvantaged groups appear to be most afflicted 
with both the disease and DM-related medical complications.
Daily management of DM can be demanding and disease-related complications 
can lead to hospitalization, disability and death. Perhaps most important from a 
psychological and behavioral perspective, patients must adhere to the demanding 
requirements of DM management while knowing that eventual onset of complications is 
almost inevitable, thus contributing to increased stress. Chronic stress related to 
medical disorders has been identified as a strong predictor of the development of 
psychopathology. Therefore, the comorbidity of mental and physical illness is of 
considerable clinical interest.
The past decade of research has seen a proliferation of studies investigating the 
comorbidity of mental and physical disease. Epidemiological studies suggest that the 
prevalence of anxiety and depressive disorders in primary care settings range from 10% 
to 30%. Although an increased prevalence of these affective disorders in patients with
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DM is suggested by the literature, biases and methodological problems commonly 
encountered in prevalence studies interfere with the strength of this conclusion (e.g., 
reliance on self-reported information). Therefore, whether an increased association 
between DM and depressive and anxiety disorders is present remains controversial 
despite an abundant body of literature dedicated to this question. Moreover, although 
an estimated 80% of diabetic men and women have type 2 DM, most studies examining 
the association between psychopathology and diabetes have focused on patients with 
type I DM.
An extensive literature reveals that social support may contribute to variability 
in the impact of chronic illness on psychological health and medical outcomes. 
Chronically ill patients who receive considerable social support have been found to be 
at decreased risk of subsequent psychopathology. However, there is some indication 
that the effectiveness of social support may depend on the type of support available and 
the specific characteristics of the disease, including functional incapacitation and degree 
of life threat.
Although prior research has established a positive contribution of social support 
to glycemic control and dietary adherence, no prior studies have examined the direct 
and buffering effects of social support in patients with type 2 DM. Additionally, no 
prior studies have examined which aspects of social support are most beneficial to 
patients with DM. Identification of these factors may have important intervention 
implications.
In conclusion, this study contributes to the literature by comparing the 
prevalence of diagnosed affective disorders in a group of socioeconomically
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disadvantaged patients with type 2 DM to those with other chronic illnesses and 
identifies the main and buffering effects of social support in decreasing the likelihood of 
having an affective disorder. This study represents the first investigation of social 
support as a moderator of the association between type 2 DM and the prevalence of 
affective disorders in a sample of low-income patients attending primary care medical 
clinics. The extent to which DM has an impact on psychopathology in this population 
is an issue that has been neglected. Therefore, further study may provide valuable 
information leading to more effective interventions for patients with type 2 DM.
Research Questions and Hypotheses 
Purpose 1: Prevalence of Depressive and Anxiety Disorder Diagnoses
The first purpose of this study was to examine the prevalence of DSM-IV 
diagnosed depressive and anxiety disorders in socioeconomically disadvantaged 
primary care patients with type 2 DM. as compared to those with other chronic illnesses 
and those with no chronic medical illnesses. Based on prior research, it was 
hypothesized that low-income. primary care patients would have a high prevalence of 
depressive and anxiety disorders in all three illness subgroups. Next, due to 
contradictory hypotheses reported in literature, no hypothesis was offered regarding the 
prevalence of depression and anxiety disorders in patients with type 2 DM versus other 
chronic illness groups. Lastly, it was hypothesized that those with no medical illnesses 
would have the lowest rates of depressive and anxiety disorders.
Purpose 2: Direct Effect of Social Support as a Predictor of an AD
The second purpose of this project was to determine whether social support 
served as an independent predictor of the incidence of an affective disorder in a group
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of primary care patients with no chronic medical disorders. It was hypothesized that 
higher rates of perceived social support would directly result in lower rates of affective 
disorders for patients with no chronic illness.
Purpose 3: Social Support as a Moderating Variable Between IG and AD
The third purpose of this project was to determine whether social support served as 
a buffer between the stress of chronic illness and the presence of an affective disorder 
for each chronic illness group (i.e., type 2 DM, other chronic illness). In view of 
previous findings, it was hypothesized that social support would help in adaptation to 
chronic illness, and hence alleviate subsequent symptoms of psychological distress. 
Therefore, social support was hypothesized to serve as an overall buffer for the 
association between stress (associated with both type 2 DM and other chronic illnesses) 
and the presence of an affective disorder. Given the extensive self-management 
requirements and the threat of eventual disabling complications, it was further 
hypothesized that social support would serve as a more important predictor for the type 
2 DM group, than for the group with other chronic illnesses.
Purpose 4: Predictive Utility of Each Tvpe of Social Support
The fourth purpose of this project was to compare the association of each type of 
social support (appraisal, tangible, belonging and self-esteem) with the presence of an 
affective disorder in each medical illness group (i.e., no medical illness, type 2 DM. 
other chronic illness). In light of prior findings, it was hypothesized that tangible social 
support would help in moderating the heavy demands associated with medical illnesses. 
However, this effect was hypothesized to be most significant in those with type 2 DM 
secondary to the increased stress associated with this functionally demanding chronic
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illness. Due to a lack of prior studies examining subtypes of social support, no 
hypotheses were offered regarding the association of the other three types of social 
support (appraisal, self-esteem, and belonging) with the prevalence of affective 
disorders in each medical illness group.
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METHODS
Participants
Participants consisted of 326 randomly selected adult African-American patients 
between the ages of 18 and 80 recruited from the Family Practice and Internal Medicine 
Clinics of Earl K. Long Medical Center (EKL) in Baton Rouge, Louisiana. The 
population from which the sample was drawn consists predominantly of patients from 
lower socio-economic status (95.3%), with an average annual income of $6240. The 
majority of the population is uninsured (77%) and receives all of their medical care 
through public providers. The population is predominantly.female (64.7%) and African 
American (77.2%). The average age is 45 years and the mean education level is 11 years.
Measures
Demographic Questionnaire
A 16-item questionnaire designed specifically to gather demographic information 
was used in the present study. This form includes questions regarding age, gender, race, 
marital status, educational level, job status, income, and insurance coverage. The 
demographic questionnaire is presented in Appendix A.
Medical Chart Review
Medical chart reviews were conducted by master’s level clinical graduate students 
under the supervision of a primary care physician to determine the presence or absence of 
the following: type 2 DM, asthma, arthritis, hypertension and no medical conditions. 
Participants diagnosed with other medical conditions (excluding the above) were 
excluded from further analyses. An additional chart review was conducted to determine 
specific medical information pertaining to patients with DM, including type of diabetes.
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Diagnostic Interview Schedule for DSM-IV (DIS-TV)
The DIS-IV (Robins, Cottier, Bucholz, Compton, 1995) is a structured interview 
designed to provide reliable and valid psychiatric diagnoses based on the Diagnostic and 
Statistical Manual of Mental Disorders-IV (APA, 1994). It was developed as a research 
tool to determine the presence of mental disorders in a variety of research settings 
including both the National Comorbidity Survey (Kessler et al., 1994) and the 
Epidemiologic Catchment Area studies (Anthony et al., 1985). Designed for use by 
trained lay interviewers, the DIS interview allows for sufficient cost containment and 
manpower utilization. Although there is currently a lack of published empirical research 
documenting use of the DIS-IV, a number of studies examining the reliability and test- 
retest reliability of the DIS-DI-R have reported ranges from .37 to .59. Additionally, 
adequate concordance validity (kappa coefficients from .47 to 1.00) has been documented 
between the diagnoses made by psychiatrists and the diagnoses of lay interviewers using 
the DIS interview (Helzer, Spitznagel, & McEvoy, 1987; Robins, Helzer, Croughan, & 
Ratcliff, 1981; Vandiver & Sher, 1991). There is also evidence for the sensitivity and 
utility of this diagnostic tool in studies of patients with diabetes, where symptoms of the 
medical disease, such as fatigue, sleep disturbances and sexual dysfunction may 
confound criterion symptoms of psychiatric disorders (Lustman et al., 1986).
For the purposes of the present study, only select DIS modules were administered 
including sections pertaining to depressive and anxiety disorders and other Axis I mental 
disorders. Modules pertaining to disorders arising in childhood (i.e. Attention Deficit 
Hyperactivity Disorder, Separation Anxiety) were not administered.
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In order to address the specific purposes of the present study, four diagnostic 
subgroups were created based on the results of the DIS-IV interview. These groups 
included (I) depressive disorders (MDD, single and recurrent, Dysthymia and Depression 
Not Otherwise Specified); (2) anxiety disorders (Panic Disorder, Social Phobia, Post- 
traumatic Stress Disorder, Obsessive Compulsive Disorder and Generalized Anxiety 
Disorder); (3) both (one or more depressive and anxiety disorder occurring during the 
prior 12 month period); and (4) none (no DIS-IV diagnosis). These groups were later 
collapsed into two groups: affective disorders (AD) included all depressive disorders, 
anxiety disorders and both, and the second group included those with no DIS-IV 
diagnoses. Participants diagnosed with psychotic disorders and dementias were excluded 
from all analyses.
Interpersonal Support Evaluation List (1SELI
The ISEL (Cohen, Mermelstein, Kamarch, & Hoverman, 1985) is a 40-item; self- 
report measure designed to assess the perception of social support availability. 
Respondents rate how accurately each item describes their access to social support on a 
four-point, Likert scale with responses ranging from definitely false (0) to definitely true 
(3). Higher ISEL scores are indicative of greater perceived social support. Examples of 
items include, “I often meet or talk with family and friends” and “If  I were sick, I could 
easily find someone to help me with my daily chores”. A total social support score is 
generated by combining scores o f the four domains tapped by the ISEL (Appraisal, 
Belonging, Self-esteem, and Tangible Support). Additionally, scores on each subscale 
can be calculated to determine four separate subscale scores. According to the Microsoft 
Flesch-Kincaid Index, the ISEL is written at a reading level of 6.2 years of education.
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Cohen, Mermelstein et al. (1985) reported good test-retest reliability for the total score, 
with reliability coefficients averaging .87. Cohen and Wills (1985) reported adequate 
concurrent and discriminant reliabilities (r = .46 and r = .64, respectively). Concurrent 
validity has been reported based on significant correlations with the Inventory of Socially 
Supportive Behaviors (Barrera, 1981) and the Moos Family Environment Scale (Folkman 
& Lazarus, 1988). Construct validation includes significant correlations with the number 
of close friends and relatives. Normative information on the ISEL is available for both 
student and general populations (McColl & Skinner, 1995). For the present study, the 
total mean score of two ISEL administrations was used.
Procedure
This study was conducted as part of a larger, ongoing study of stress and 
psychopathology in medical utilization funded by the National Institute of Mental Health 
[NIMH] (R01 MH51194-01AI). The IRB Approval is enclosed in Appendix B. 
Randomly selected patients were approached in the waiting rooms of primary care clinics 
and asked to participate in the study. The study protocol was explained to all interested 
subjects and all questions were answered. In order to assure that all participants 
understood their rights and the procedures involved, a consent form (Appendix C) was 
signed by all participants prior to study participation. The low literacy rate in this 
population occasionally necessitated an offer to provide some assistance in explaining the 
consent form to assure adequate comprehension. Upon completion of the consent form, a 
demographic questionnaire and other measures pertinent to the larger study were 
completed by each subject. Participants completed a battery of self-report inventories
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including the first of two administrations of the ISEL. Participants were compensated 
$35 for the completion of these forms.
In order to increase subject retention, all participants were contacted by telephone 
on a randomly selected day every other month to administer a variety of measures o f life 
stress. During the twelve-month follow-up interview, participants' self- administered the 
second ISEL questionnaire. Additionally, each participant was interviewed with the 
Diagnostic Interview Schedule for the DSM-IV (DIS-IV). Participants were paid $50.00 
upon completion of the twelve-month interview and questionnaires. At this time, a chart 
review was performed by a primary care physician and a graduate student to determine 
the presence and number of chronic illnesses. An additional chart review was later 
completed to document illness specific information (i.e. type of diabetes) (See Table 1).
Table 1: Timeline of Administration of Measures
Measure Recruit Call 1 Call 2 Call 3 Call 4 Call 5 Interview
(0 mo) (2 mo) (4 mo) (6 mo) (8 mo) (10 mo) (12 mos)
Demogs X
ISEL X X
DIS X
Other X X X X X X X
Chart Review X
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Preliminary Power Analyses 
In order to determine if the proposed sample size (N = 400) was sufficient to 
detect a significant chi-square, a power analysis was performed (Precision and Power; 
Borenstein, Rothstein. Cohen. Schoenfeld & Berlin, 2000). The proposed sample size 
of 400 was assigned as follows: 25% in the type 2 DM group, 65% in the other chronic 
illness group and 10% in the no chronic illness group. Based upon the results of prior 
studies, it was further estimated that approximately 20% of both the Type 2 DM group 
and the other chronic illness group would suffer from a depressive disorder, another 
20% an anxiety disorder; approximately 20% would have experienced both disorders 
during the past year and the remaining 40% would suffer from no DSM-IV diagnosis 
occurring during the prior 12-month period. According to prior prevalence studies 
conducted in primary care populations, it was estimated that 10% of the group with no 
medical illness would suffer from a depressive disorder, 10% from an anxiety disorder, 
10% from both and 70% would have no diagnosed psychopathology. With the 
proposed sample size of 400, the present study was estimated to have power of 78.6% 
to detect an effect size of .182. assuming an alpha of .05 (2-tailed) (See Table 2).
Table 2: Power Analysis for 3X4 Chi-Square (Power =.79)
Percentage of Patients Predicted in EachCell Proportion 
In RowDepression Anxiety Both None
Tvpe 2 
Dm
.20 .20 .20 .40 .25
Other
Illness
.20 .20 .20 .40 .65
No Illness .10 .10 .10 .70 .10
Unfortunately, power for logistic regression (LR)analyses using combinations of 
predictor types (categorical and continuous predictors) is not well defined; therefore, to
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determine sample size needed, a series of power analyses were conducted. One goal of 
the proposed study was to test the null hypothesis that the event rate or the proportion of 
each group having an affective disorder was identical. Thereby, the odds ratio was set 
at 1.0 and the relative risk at 1.0. In a LR, the effect size is determined by two 
elements, the proportion of subjects in each group and the relationship between the 
predictor (i.e., IG, SS) and outcome (how the rate of affective disorders varies between 
groups). The event rate was preset for .30 to correspond to the proportion of the group 
with no chronic illness hypothesized to have an affective disorder. For this distribution, 
effect size (event rates of .60, .60, .30), sample size (400), and alpha level (.05,2- 
tailed), power was determined to be .88. This indicates that in a LR analysis with one 
categorical predictor with three levels (IG), 89% of studies would be expected to yield a 
significant effect (See Table 3). When power was computed for a LR comparing only 
the type 2 DM group to those with other chronic illness, the power was reduced to .72. 
Table 3: Power Analysis for a Single Categorical LR Analysis (Power = .88)
Relative
Proportion
Event Rate Odds Ratio Relative Risk
Type 2 Dm 25 .60 1.00 1.00
Other Illness 65 .60 1.00 1.00
No Illness 10 .30 .30 .50
Given that another goal of the proposed study was to test the null hypothesis that 
no relationship existed between perceived social support (SS) and the presence of an 
affective disorder, a power analysis for a LR with one continuous predictor (i.e., SS), 
was calculated. For this analysis, the predicted mean for SS was calculated at a 
hypothesized score of 100 with 1 standard deviation (10). The predetermined event 
score was computed given the hypothesis that 35% of the sample would score > 1 SD
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below the mean. Therefore, the odds ratio, or the odds of having an affective disorder 
were computed at .76, and the corresponding relative risk was calculated at .83. For 
this distribution, power was determined to be .70, indicating that 70% of studies would 
be expected to yield a moderate effect (.35), rejecting the null hypothesis that the odds 
of having an affective disorder are equal (See Table 4). It can thus be hypothesized that 
the results of these power analyses suggest that the proposed sample size o f400 was 
sufficient to detect a significant finding using LR analyses with one categorical and one 
continuous variable.
Table 4: Power Analysis for a Single Continuous LR Analysis (Power = .70)
Distribution Of Predictor 
Rate At Mean Of Prec
ind Event 
ictor
Effect Size
Predictor
Mean
SD Event
Rate
Odds
Ratio
Relative Risk
Social Support 100 .10 .35 .76 .35
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RESULTS 
Preliminary Descriptive Analyses
Demographic Data
The original sample consisted o f429 randomly selected adult patients between 
the ages of 18 and 80 recruited from the Family Practice and Internal Medicine Clinics 
of Earl K. Long Medical Center (EKL) in Baton Rouge, Louisiana. Upon initial review 
of the data, it was determined that 12 participants were diagnosed with psychotic 
disorders including schizophrenia, schizoaffective disorder and schizophreniform 
disorder or dementia. Therefore, these persons were excluded from further analyses. 
Additionally, 14 of the remaining 417 participants had extensive missing data and were 
eliminated from further analyses. Demographic information on the remaining 
participants (N=403) are detailed in Appendix D.
Of the 403 participants, 77 participants were diagnosed with a variety of other 
chronic conditions (e.g., GERD, cancer, etc.) not including DM, hypertension, arthritis 
and asthma. As the apriori goals for the present study were to compare patients with 
type 2 DM against those with hypertension, asthma and arthritis and against those with 
no medical illness, these patients with other medical conditions were eliminated from 
further analyses. The remaining participants (N = 326) were used in all analyses.
Based on the results of the DIS-IV interview, four groups were formed. 
Participants meeting diagnostic criteria for the following affective disorders occurring 
during the course of the prior 12-month period were included in all analyses: Major 
Depressive Disorder, single or recurrent, Dysthymia and Depression Not Otherwise 
Specified; Panic Disorder, Social Phobia, Post-traumatic Stress Disorder, Obsessive
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Compulsive Disorder and Generalized Anxiety Disorder; one or more depressive and 
anxiety disorders occurring during the prior 12-month period; and those with no DIS-IV 
diagnosis occurring over the prior 12-month time period. These groups were later 
collapsed into two groups: affective disorders (AD) included all depressive disorders, 
anxiety disorders and both, and the second group included those with no DIS-IV 
diagnosis.
In order to generate a profile of the sample, descriptive statistics were 
calculated for all categorical and continuous variables and appear in Tables 5 and 6.
The sample was predominantly female (80.4%) and African American (74.0%). 
Twenty-five percent of the sample was married. Fifty -nine percent of the sample was 
unemployed. The majority (77.2%) of the population had no health insurance; therefore 
it can be assumed that the greater part of the sample receives all of their medical care 
through public hospital providers.
As illustrated in Table 5. the average age of the sample (N = 326) was 47.2 (SD 
13.91) years and the mean education level was 11.1 (SD 2.72) years. The sample 
consisted of patients with an average monthly income of $498.19 (SD 451.06). The 
average body mass index was 31.03 (SD 8.56) and the number of chronic illnesses for 
the sample was 2.60 (SD 1.52). Overall, the sample was representative of the 
demographic profile of patients seen at public primary care clinics in the state of 
Louisiana (Brantley, Carmack, Boudreaux, & Scarinci, 1996).
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Table 5: Demographic Data for the Sample (N = 326) (Categorical Variables)
Variable Frequency 
N = 326
Percent
Gender:
Female
Male
262
64
80.4
19.6
Race:
Black 242 74.2
White 83 25.5
Hispanic 1 .3
Marital Status:
Married 81 24.9
Single 121 37.2
Other 123 37.8
*Job Status:
Unemployed 190 59.0
Employed 132 41.0
Insurance:
None
Medicare
Medical
Private
251
28
21
25
77.2
8.6
6.5
7.7
Table 6: Demographic Data for the Sample (N = 326) (Continuous Variables)
Variable Mean SD Range
Age 47.28 13.91 18-78
Education 11.10 2.72 0-16
Income 498.19 451.06 0-3600
BMI 31.03 8.56 16.9-70.0
# chronic illnesses 2.60 1.52 0-8
Measurement Data (ISEL)
Descriptive statistics were calculated for the total ISEL score (average of two 
administrations) and each ISEL subscale (Appraisal, Tangible, Belonging, Self-esteem) 
score. Table 7 illustrates the means and standard deviations of each. For comparative 
purposes, Table 7 also includes a description of normative data collected on the 
multiple-choice version of the ISEL (Cohen et al., 1985). The mean total score for the
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ISEL was 88.92 (SD 17.07). The mean total for the appraisal subscale score was 21.44
(SD 5.31), the tangible subscale was 23.41 (SD 5.42); the self-esteem subscale was
21.60 (SD 3.99) and the belonging subscale was 22.49 (SD 4.73). As is indicated in
Table 7, the perceived social support subscale scores reported by the sample were
significantly lower than that of the normative sample, comprised of community subjects
(34.69 - 35.40) (Schonfeld, 1991). No significant differences were identified between
any of the three illness groups in total social support or subscale scores.
Table 7: Means and Standard Deviations of the Normative and Sample Data for the 
ISEL Total and Subscale Scores
Normed 
Data 
Means (SD)
Sample Data 
(N = 326) 
Means (SD)
Type 2 
DM
Other
Chronic
Illnesses
No Illness
Total score 88.92 (17.07) 86.6(18.2) 89.0(16.5) 92.6(15.8)
Subscales;
Appraisal 35.40 (4.58) 21.44(5.31) 20.35 (5.7) 21.68 (5.0) 22.72 (4.8)
Tangible 36.13 (3.78) 23.41 (5.42) 22.63(6.1) 23.65 (5.1) 24.11 (4.8)
Self-esteem 33.36 (3.48) 21.60(3.99) 21.35 (4.0) 21.42(4.1) 22.55 (3.4)
Belonging 34.69 (4.92) 22.49(4.73) 22.30 (5.1) 22.34(4.5) 23.23 (4.3)
Power Analyses
Power of Chi-Square Analyses
Given the change in sample size following the elimination of participants 
excluded for other medical conditions, a second series of power analyses was 
performed. In order to determine if the actual sample size of 326 was sufficient to 
detect a significant chi-square, the original power analysis was modified to reflect 
actual distributions determined by the preliminary descriptive analyses. Accordingly, 
30% of the sample was assigned to the type 2 DM group, 50% to the other chronic 
illness group and 20% to the no illness group. It was estimated that approximately 20%
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of both the type 2 DM group and the other chronic illness group would suffer from a 
depressive disorder, another 20% from an anxiety disorder, approximately 20% would 
have experienced both disorders during the past year and the remaining 40% would 
suffer from no DSM-IV diagnosis occurring during the prior 12-month period. 
According to prior prevalence studies conducted in primary care populations, it was 
estimated that 10% of the group with no medical disorder would suffer from a 
depressive disorder, 10% from an anxiety disorder, 10% from both and 70% would 
have no diagnosed psychopathology. These distributions convert to an effect size of 
.241. Based on the Power and Precision program (Borenstein et al., 2000), the present 
study was determined to have power of 92.5% to detect an effect of this magnitude. As 
indicated in Figure 1. power reaches .80 at approximately a sample size of 250.
Power a s  a  Function of Sam ple S ize
0.8
0.6
0.4
0.2
0.0
0 100 200 300 400 500
Sample Size
Figure 1: Power analysis for 3 X 4 Chi-square (N = 326)
Power of Logistic Regression Analyses
In order to determine if the actual sample size was sufficient to detect a 
significant logistic regression with one continuous and one categorical predictor, several 
additional power analyses were conducted. One goal of the present study was to test the
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null hypothesis that the event rate of AD is identical in the three illness groups. 
Therefore, power was computed based on the results of descriptive statistics. The 
diagnostic groups occurred in the following proportions: 30% type 2 DM, 50% other 
chronic illnesses and 20% no medical illnesses. The event rate of AD was set at 50% 
for those with type 2 DM, 50% for those with other chronic illnesses and .30 for those 
with no illness. For this distribution, effect size (event rates of .50, .50, .30), sample 
size (326), and alpha level (.05, 2-tailed), power is .82. This indicates that in a LR 
analysis with one categorical predictor with three levels (IG), 82% of studies would be 
expected to yield a significant effect, rejecting the null hypothesis that the event rates 
are identical (See Figure 2).
Pow er a s  a  Function of Sam ple S ize
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0.2
0.0
100 200 300 4 00 7000 500 600
Total Sample Size
Figure 2: Power Analysis for a Single Categorical LR Analysis (N = 326)
Given that another goal of the proposed study was to test the null hypothesis that 
no relationship exists between perceived social support (SS) and the presence of an 
affective disorder, a second power analysis for a LR with one continuous predictor (i.e., 
SS) was calculated. For this analysis, the mean for SS was calculated at 90 (based on 
the observed ISEL mean score of 89.92) with event rate reduction with every one
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standard deviation (17). For this distribution, power was determined to be .78, 
indicating that 78% of studies would be expected to reject the null hypothesis that the 
odds of having an affective disorder are equal (See Table 10). The results of these 
power analyses suggest that the current sample size was sufficient to detect a significant 
finding using LR analyses with one categorical and one continuous variable (See Figure 
3).
Power as a Function of Sample Size
0.7
0.6
0.4
0J
0 100 300 400200 500 600 700
Total Sample Size
Figure 3: Power Analysis for a Single Continuous LR Analysis (N = 326)
Preliminary Descriptive and Inferential Analyses 
The Statistical Package for the Social Sciences (1994) program was used for all 
statistical analyses. In order to compare and contrast each medical illness group, (IG. 
[no medical illness, type 2 DM, and other chronic illnesses]) descriptive and inferential 
statistics were calculated. Additionally, each psychiatric diagnostic group (depression 
only, anxiety only, both and no DSM-IV diagnoses) was compared. Lastly, descriptive
63
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
and inferential analyses were conducted to examine the sample when divided into those 
with an affective disorder (AD [depression only, anxiety only and both]) and those with 
no affective disorder or other DSM-IV diagnoses. These results will be presented in 
three sections: Illness Groups, Diagnostic Groups and Affective Disorder Groups. 
Medical Illness Groups
Table 8 delineates the demographic representation of each medical illness group 
and the results of chi-square comparative analyses. Results of these preliminary 
analyses indicate that 17.8% (n = 58) of the sample had no chronic illnesses, 31.9% (n = 
104) had been diagnosed with type 2 DM and 50.3% (n =164) had HTN, asthma or 
arthritis (“other chronic illness”), but not type 2 DM.
Inferential statistics were computed to identify significant differences in each 
categorical demographic variable (gender, race, marital status, job status and insurance 
coverage). Results of the chi-square analyses found no significant differences were 
found in race (x2 = 6.25, p <.181), and insurance coverage (x2 = 5.73, p <.453). 
However, results of the chi-square analysis identified significant group difference in 
gender distribution (x2 = 9.46,p < .009), marital status (x: = 41.57, p < .000), and job 
status (x: = 9.46, p <.009) (See Table 8).
Specifically, analyses of standard residuals showed that a significantly smaller 
percentage of males than expected were found in the no illness group as compared to 
those with type 2 DM. Additionally, a significantly smaller percentage of females were 
diabetic as compared to those who had no medical illness. No gender differences were 
observed between those with type 2 DM and those with other chronic illnesses. Next, 
analyses showed that a higher than expected number of participants in the group with no
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medical illness were single as compared with the type 2 DM and the other illness group. 
Additionally, the group with no medical illness also had fewer participants indicating 
that their marital status was “other” (separated, widowed, cohabitating) than either 
medical illness group. No statistically significant differences in marital status were 
identified between those with type 2 DM and those with other chronic medical illnesses. 
Lastly, a significantly higher percentage of patients with no medical illness were 
employed as compared to those with type 2 DM and those with other chronic illnesses. 
Additionally, those with type 2 DM had a higher percentage of unemployment as 
compared to those with other chronic illnesses and those with no medical illness.
Table 8: Percentages. Number of Cases, and Chi-Square Significance of each 
Categorical Demographic Variable for each Medical Illness Group (N=326)
Variable No Medical 
Illness 
n = 58
Type 2 DM 
n=  104
Other Chronic 
Illness 
n = 164
P
Gender:
Female
Male
93.1% (54) 
6.9% (4)
73.1% (76) 
26.9% (28)
80.5% (132) 
19.5% (32)
.009**
Race:
Black
White
Hispanic
72.4 % (42) 
25.9% (15) 
1.7% (1)
78.8% (82) 
21.2% (22) 
0% (0)
72.0% (118) 
28.0%(46) 
0% (0)
.18 NS
Marital Status: 
Single 
Married 
Other
50.9% (29) 
38.6% (22) 
10.5% (6)
16.3% (17) 
48.1% (50) 
35.6% (37)
21.3% (35) 
29.9% (49) 
48.8% (80)
.000**
Job Status: 
Unemployed 
Employed
44.8% (26) 
55.2% (32)
69.2% (72) 
30.8% (32)
57.5% (92) 
42.5% (68)
.009**
Insurance:
None
Medicare
Medicaid
Private
81.0% (47) 
3.4% (2) 
6.9% (4) 
8.6% (5)
76.9% (80) 
12.5% (13) 
3.8% (4) 
6.7% (7)
76.1% (124) 
8.0% (13) 
8.0% (13) 
8.0% (13)
.45 NS
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Results of an ANOVA identified significant group differences in age (F = 55.40, 
df 2, p < .000); education (F = 15.75, df 2, p < .000) and number of chronic illnesses 
(F = 133.37, df 2, p < .000). No significant differences were identified in monthly 
income (F= .78, df 2, p<  .459) (See Table 9). Post-hoc analyses identified that those 
with no chronic illness were significantly younger than those with either type 2 DM or 
other chronic illnesses; however, no significant age differences were identified between 
those with type 2 DM and those with other chronic illnesses. Not surprisingly, those 
with no medical illnesses had significantly fewer chronic illnesses than either those with 
type 2 DM or other illnesses, however, no significant differences emerged when post 
hoc analyses compared those with type 2 DM versus those with other illnesses. Lastly, 
all three groups differed significantly in number of years of education. Specifically, 
those with no medical illness completed the highest number of years of education 
(12.5); followed by those with other chronic illnesses (11.1) and those with type 2 DM 
( 10. 1).
The Levine test of homogeneity of variances indicated that the data violated the 
parametric assumption of homogeneity in education level (7.3, df 2, p < .001) and 
number of chronic illnesses (7.36, df 2, p < .001). Given these violations, two separate 
Kruskal Wallis Tests were computed. Results of the Kruskal Wallis also found a 
significant difference between the three illness groups in education level C/C- 30.13, p 
< .000) and number of chronic illnesses (%' = 138.24, p < .000).
66
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 9: Means. SD. F Values. DF and ANOVA Significance of each Continuous
Demographic Variable for each Medical Illness Group (N = 326)
Variable Mean SD F (df) P Kruskal 
Wallis Test
Age
No Chronic Illness 
Type 2 DM 
Other Chronic Illness
32.19
50.59
50.52
11.34
12.18
12.19
55.40 (2) .000** N/A
Education
No Chronic Illness 
Type 2 DM 
Other Chronic Illness
12.55
10.16
11.19
1.69
3.04
2.56
15.75 (2) .000** .000**
# Chronic Illnesses 
No Chronic Illness 
Type 2 DM 
Other Chronic Illness
.431
3.29
2.93
.651
1.21
1.20
133.37 (2) .000** .000**
Income
No Chronic Illness 
Type 2 DM 
Other Chronic Illness
496.42
455.34
525.99
393.98
460.02
464.45
.780 (2) .459 NS N/A
Diagnostic Groups
Table 10 delineates the demographic representation of each diagnostic group 
(depression only, anxiety only, both anxiety and depressive disorder occurring during 
the past year, and no DSM-IV diagnoses) and the results of chi-square comparative 
analyses. Results of these preliminary analyses indicated that 10.1% (n = 33) of the 
sample suffered from a depressive disorder occurring during the past year, another 
10.1% (n = 33) from an anxiety disorder, 8.6% (n = 28) met diagnostic criteria for both, 
and 71.2% (n = 232) had no DSM-IV psychiatric disorder in the past year.
Inferential statistics were computed to identify any significant differences 
between each diagnostic group on each categorical demographic variable (gender, race, 
marital status, job status and insurance coverage). No significant differences were 
found in gender (x2=5.67, p  < .129), race (x2 = 4.57, p < .600), marital status (x2 =
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9.26, p  < .159), and insurance coverage (%' = 9.51, p  < .392). However, results of the 
chi-square analysis identified significant differences in each diagnostic groups in terms 
of job status (x2 = 8.01. p  <.046) (See Table 10). Specifically, a smaller percentage of 
those with anxiety only were employed than those with no DSM-IV diagnoses and 
those with depression only. This difference in job status was most apparent when 
examining the group diagnosed with both a depressive and an anxiety disorder. Those 
diagnosed with both disorders in the past year had higher rates of unemployment than 
any of the diagnostic groups. No statistically significant differences were observed in 
rates of employment in those with no DSM-IV diagnoses as compared to those with 
depression only.
Table 10: Percentages. Number of Cases. And Chi Square Significance of Each 
Categorical Demographic Variable for Each Diagnostic Group (N=326)
Variable No DX 
n = 232
Depression 
Only 
n = 33
Anxiety 
Only 
n = 33
Both 
n = 28
P
Gender:
Female
Male
77.2% (179) 
22.8% (53)
90.9% (30) 
9.1% (3)
84.8% (28 
15.2% (5)
89.3% (25) 
10.7% (3)
.129 NS
Race:
Black
White
Hispanic
75.8% (176) 
23.7% (66) 
.4% (1)
60.6% (20) 
39.4% (13) 
0% (0)
78.8% (26) 
21.2% (7) 
0% (0)
71.4% (20) 
28.6% (8) 
0% (0)
.600 NS
Marital Status: 
Single 
Married 
Other
28.4% (66) 
35.3% (82) 
36.2% (84)
21.2% (7) 
33.3% (11) 
45.5% (15)
6.3% (2) 
53.1% (17) 
40.6% (13)
21.4% (6) 
39.3% (11) 
39.3% (11)
.159 NS
Job Status:
Unemployed
Employed
59.8% (137) 
40.2% (92)
54.5 % (18) 
45.5% (15)
42.4% (14) 
57.6% (19)
77.8% (21) 
22.2% (6)
.046*
Insurance:
None
Medicare
Medicaid
Private
76.7% (178) 
9.5% (22) 
7.3% (17) 
6.5% (15)
72.7% (24) 
9.1% (3) 
9.1% (3) 
9.1% (3)
81.3% (26) 
0%(0) 
3.1% (1) 
15.6% (5)
82.1% (23) 
10.7% (3) 
0% (0) 
7.1% (2)
.392 NS
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Table 11 delineates the results of both the descriptive statistics computed to 
describe the continuous demographic variable representation of each diagnostic group 
and the results of parametric tests conducted to identify any significant differences 
between these groups on the continuous demographic variables (age, education, number 
of comorbid medical illnesses and monthly income). Results of the ANOVA found no 
significant group differences in age (F = 2.14, df 3,p < .095); number of chronic 
illnesses (F= .646, df 3, p < .586) and monthly income (F = 1.90, df 3, p  < .129). 
Although education was found to be significantly different (F = 3.39, df 3, p < .018) in 
the overall ANOVA, interestingly, post hoc analyses failed to identify any significant 
differences when all four diagnostic groups were compared (.081 -  1.00). Upon close 
examination of the education mean scores, it appears that the statistically significant F 
test is accounted for by the fact that the group with no DSM-IV diagnosis has the lowest 
mean education level (10.81) and the other three diagnostic groups (depression only, 
anxiety only, both) had higher, albeit, very similar mean scores (12.10,11.75, 11.60. 
respectively). Therefore, the significant difference is found when the no DSM-IV group 
is compared against the other three diagnostic groups.
The groups were found to have heterogeneous variances in monthly income 
(Levine statistic 2.64, df 3, p < .049). Therefore, given the violation of the parametric 
assumption of homogeneity of variances. Kruskal Wallis Test was computed. Results of 
the Kruskal Wallis also did not find a significant difference between the four diagnostic 
groups in regards to income (x2~ 5.673, p <.129) (See Table 11).
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Table 11: Means. SD. Df. F Values and ANOVA Significance of each Continuous
Demographic Variable for each Diagnostic Group (N = 326)
Variable Mean SD F (df) P Kruskal- 
Wallis Test
Age 2.14(3) .095 NS N/A
No DSM-IV DX 48.14 14.40
Depressed Only 46.18 13.37
Anxiety Only 47.45 11.13
Both 41.25 12.32
Education 3.39(3) .018* N/A
No DSM-IV DX 10.81 2.80
Depressed Only 12.10 2.69
Anxiety Only 11.75 2.25
Both 11.60 2.13
# Chronic Illnesses .646 (3) .586 NS N/A
No DSM-IV DX 2.54 1.46
Depressed Only 2.93 1.39
Anxiety Only 2.66 1.77
Both 2.60 1.83
Income
No DSM-IV DX 
Depressed Only 
Anxiety Only 
Both
478.83
558.31
647.45
411.85
437.74
454.75 
502.93 
471.33
1.90(3) .129 NS .129 NS
Affective Disorders Groups
Table 12 delineates the demographic characteristics and group differences 
between those in the sample with and without an affective disorder. As was previously 
mentioned, the affective disorder category was defined to include those meeting criteria 
for a depressive disorder only, an anxiety disorder only and both a depressive and an 
anxiety disorder occurring during the past year. Results of these preliminary analyses 
indicated that 28% (n = 94) of the sample suffered from an affective disorder and 71.2% 
(n = 232) did not meet DIS-IV diagnostic criteria for an affective disorder or any other 
psychiatric disorder occurring during the past year.
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Inferential statistics were computed to identify any significant differences 
between those with and without an affective disorder diagnosis on each categorical 
demographic variable (gender, race, marital status, and job status and insurance 
coverage). Results of the chi-square analysis identified no significant differences 
between the two affective disorder groups in terms of race (x2 = 1.66, p  < .435), marital 
status, (x2 = 5.39, p < .067), insurance coverage (x2 = 3.26, p < .353), or job status (x2 
=220. p  < .639). However, a significant difference was identified between the two 
groups in terms of gender (X2 = 5.26, p  < .02). Specifically, a significantly smaller 
percentage of males had an affective disorder than expected when compared to the 
percentage identified in females.
Table 12: Percentages. Number of Cases, and Chi-Square Significance of each 
Categorical Demographic Variable for each Affective Disorder Group (N = 326)
Variable No Affective 
Disorder 
n = 232
Affective 
Disorder 
n = 94
P
Gender:
Female
Male
77.2% (179) 
22.8% (53)
88.3% (83) 
11.7% (11)
j022*
Race:
Black
White
Hispanic
75.9% (176) 
23.7% (55) 
.4% (1)
70.2% (66) 
29.8% (28) 
0% (0)
.435 NS
Marital Status: 
Single 
Married 
Other
28.4% (66) 
35.3% (82) 
36.2% (84)
16.1% (15) 
41.9% (39) 
41.9% (39)
.067 NS
Job Status: 
Unemployed 
Employed
59.8% (137) 
40.2% (92)
57.0% (53) 
43.0% (40)
.364 NS
Insurance:
None
Medicare
Medicaid
Private
76.7% (178) 
9.5% (22) 
7.3% (17) 
6.5% (15)
78.5% (73) 
6.5% (6) 
4.3% (4) 
10.8% (10)
.353 NS
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Table 13 illustrates the results of both the descriptive statistics and parametric 
tests conducted to identify any significant differences between those with and without 
an affective disorder on each continuous demographic variable (age, education, number 
of comorbid medical illnesses, monthly income). Results of the ANOVA found no 
significant group differences in age (F = 3.08, df 1 ,p < .08), number of chronic 
illnesses (F= 1.09, df 1, p < .29) and monthly income (F = 1.48, df 1, p < .22).
However, results of the ANOVA found significant group differences in education (F = 
9.65, df 1, p < .002). Specifically, those with an affective disorder had a higher number 
of years of education than those with no DSM-IV diagnosis (11.83 Vs. 10.81. 
respectively).
Table 13: Means. SD. DF. F Values and ANOVA Significance of each Continuous 
Demographic Variable for each Affective Disorder Group (N=326)
Variable Mean SD F P Kruskal-
WallisTest
Age
No Affective Dx 
Affective Disorder
48.14
45.16
14.40
12.45
3.08 .08 NS .04*
Education
No Affective Dx 
Affective Disorder
10.81
11.83
2.80
2.36
9.65 .002** .002**
# Chronic Illnesses 
No Affective Dx 
Affective Disorder
2.54
2.74
1.46
1.65
1.09 .29 NS N/A
Income
No Affective Dx 
Affective Disorder
478.83
545.98
437.74
481.46
1.48 .22 NS .461 NS
The groups were found to have heterogeneous variances in age (Levine statistic 
3.95, p < .048): education (4.02, p  < .046); and monthly income (8.28, p < .004). 
Therefore, given the violation of the parametric assumption of homogeneity of 
variances, a Kruskal Wallis Test was computed. Results of the Kruskal Wallis found a
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significant difference between the two affective disorder groups in age (x2 = 4.19, p 
<.04) and education (x2 = 9.5, p < .002). Kruskal-Wallis Test did not identify 
significant differences in income (x2= .544, p < .461).
Preliminary Logistic Regression 
A preliminary logistic regression (LR) was conducted in order to identify 
potential confounds as possible covariates in later analyses. A backward stepwise LR 
was conducted using a significance of p < .05 to retain variables in the model. Based on 
the above preliminary univariate chi-square and ANOVA results, the only potentially 
significant demographic predictors of an AD diagnosis were gender, marital status, age, 
job status and education. Therefore, these potential confounds were entered as a block. 
As seen in Table 14, the model for demographic variables indicated that higher rates of 
affective disorders were associated with gender and education.
Table 14: Preliminary Backward LR of Demographic Variables as Predictors of AD
Variable B Wald (df) P Odds
Ratio
95% C.I. for Odds 
Lower Upper
Gender (female) .699 3.63(1) .054 NS 2.012 .987 4.09
Education .150 7.80(1) .005* 1.162 1.046 1.292
Constant -2.497 15.15(1) .000** .082 ----- -----
Explicitly, results of the preliminary LR identified that women had increased 
odds of having an affective disorder by 2.01 or by 101%. As education increased, the 
probability of developing an affective disorder increased by a multiple of 1.162 or by 
16% for each year of education. Given that gender was approaching significance at the 
p < .05 level (p < .054) and considering the theoretical evidence relating gender to the 
prediction of an AD diagnosis (i.e., rates are approximately 2:1 for females), gender
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will be treated as a potential confound in the present study. Therefore, both gender and 
education will be statistically controlled in further analyses.
Main Analyses
Data Analyses
In order to fulfill the objectives of the current study, descriptive and chi-square 
analyses were conducted, followed by two separate logistic regression analyses. In the 
first LR model, gender and education were entered as the first block, followed by IG in 
block 2. In subsequent analyses, social support was entered as block 3 and the 
interaction of social support and illness group was entered as block 4. The first overall 
LR model is detailed in Table 19. In the second LR analysis, gender and education 
were entered into the first block, followed by IG in the second block and each type of 
social support was entered simultaneously into the third block. Based upon the results 
of this LR, subsequent blocks were added to the model to test the pertinent hypothesis. 
Purpose 1: Prevalence of Depressive and Anxiety Disorder Diagnoses
The first purpose of the present study was to compare and contrast the rates of 
DSM-IV affective disorders for each medical illness group (no illness, type 2 DM and 
other chronic illness). Descriptive statistics were used to generate a profile of each 
illness group based on the presence of depression only, anxiety only, both anxiety and 
depression occurring during the past year and those with no DSM-IV diagnosis. As 
illustrated in Table 15, 28% (n = 94) of the total sample met diagnostic criteria for a 
DSM-IV affective disorder during the prior 12month period. Specifically, 10% (n = 
33) met criteria for a depressive disorder only, 10% (n = 33) met criteria for an anxiety
74
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
disorder only, and 8.6% (n = 28) met criteria for both a depressive and an anxiety 
disorder, occurring during the past year.
Inferential statistics were computed to identify any significant differences in the
prevalence of depression, anxiety, both and no DSM-IV diagnosis in each medical
illness group. In order to determine if there were any significant differences between
each illness group in terms of prevalence of an affective disorder diagnosis, a 3 by 4
chi-square was conducted. Results of the chi-square analysis identified no significant
differences in the rates of affective disorders in patients with Type 2 DM as compared
to those with other chronic illnesses in the prevalence of depressive or anxiety
disorders. Although it was hypothesized that a significant difference in rates of
depression and anxiety disorders would be observed when the chronic illness groups
were compared to those with no chronic medical illnesses, results of chi-square failed to
identify a significant difference (X2 = 8.18. df 6, p < .225) (See Table 15).
Table 15: Descriptive Statistics and Overall Chi-Square Results of the Prevalence of 
DSM-IV Diagnoses within each Medical Illness Group
Total 
Sample 
N = 326
No Chronic 
Illness 
N = 58
Type 2 DM 
n=  104
Other Chronic 
Illness 
n = 164
P
DX groups: 
No DX 71.2% (232) 69.0% (40) 64.4% (67) 76.2(125)
.22 NS
Depression Only 10.1% (33) 6.9% (4) 12.5% (13) 9.8% (16)
Aaxiety Only 10.1% (33) 12.1% (7) 10.6% (11) 9.1% (15)
Both 8.6% (28) 12.1% (7) 12.5% (13) 4.9% (8)
As was previously described, in order to compare the prevalence of affective 
disorders versus no DSM-IV diagnosis in the three medical illness groups, the four 
diagnostic groups were collapsed into two categories, affective disorders and no DSM- 
IV diagnoses. Descriptive statistics were used to generate a profile of the sample based
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on the rates of psychopathology in each illness group. As is illustrated in Table 16, the 
vast majority of the total sample (71%, n = 232) did not meet diagnostic criteria for a 
DSM-IV diagnostic disorder.
In order to determine if there were any significant differences between each 
illness group in terms of prevalence of an affective disorder, a 3 by 2 chi-square was 
conducted. Results of the chi-square analysis identified no significant differences in the 
rates of affective disorders in patients with Type 2 DM as compared to those with other 
chronic illnesses. It was hypothesized that a significant difference would be observed 
when the chronic illness groups were compared to those with no medical illness; 
however, results of the chi-square analysis found no significant differences between any 
of the three illness groups in terms of prevalence of affective disorders (X2 = 4.48, df 2, 
p < .106) (See Table 16).
Table 16: Descripdve Statistics and Overall Chi-Square Results of the Prevalence of an 
AD for the Total Sample and Within Each Illness Group
Total 
Sample 
N = 326
No Chronic 
Illness 
n = 58
Type 2 DM 
n =  104
Other Chronic 
Illness 
n = 164
P
Diagnostic group 
No DX 71.2% (232) 69.0% (40) 64.4% (67) 76.2% (125)
.10 NS
AD 28.8% (94) 31.0% (18) 35.6% (37) 23.8% (39)
In order to determine whether IG would predict a diagnosis of AD after the 
influence of confounds were controlled, the first of two logistic regression analyses 
were conducted. As prior analyses indicated that gender and education level were 
potential confounds, these variables were statistically controlled in the model. Thus, the 
outcome variable was affective disorder (AD) and the predictors were gender, 
education, and IG.
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Results of the overall hierarchical LR model found a significant main effect for 
gender, education, and IG. Specifically, when gender and education were entered 
together in block 1. a significant main effect was found (X2 -  14.30, df 2, p < .001). 
Results of the LR indicated that the odds of having an AD increase by a multiple of 2.01 
or by 101% for females (since [2.01-1] * 100 = 101). Additionally, the odds of having 
an AD increased by a multiple of 1.16 or by 16% for each year increase in education.
In block 2, illness group (IG) was entered and a significant main effect was 
observed (X * = 22.66, df 4. p < .000). As is indicated in Table 17, a significant main 
effect for IG suggests that the presence of a chronic illness is a significant predictor of 
AD when gender and education are controlled. Interestingly, although a significant 
main effect was found for the overall illness group model, after examining post-hoc 
comparisons, it appeared that the only significant medical illness contrast occurred 
when comparing those with type 2 DM with those with other chronic illnesses. Hence, 
when gender and education are controlled, the odds of having an AD increased for those 
with type 2 DM by a multiple of 2.26 or by 126% as compared to those with other 
chronic medical illnesses. When those with type 2 DM were compared with those with 
no chronic illness, results failed to meet significance at the p < .05 level; however, 
results indicated that the data approached significance at p < .052. Hence, these results 
may identify a trend for the odds of having an AD to increase for those with type 2 DM 
by 198% as compared to those with no chronic illness.
77
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 17: Hierarchical LR Results of Gender. Education, and IG
Variable P Wald (df) P Odds
Ratio
95% C.I. Odds 
Lower Upper
Gender .802 4.57(1) .033* 2.22 1.06 4.64
Education .181 9.57(1) .002** 1.19 1.06 1.34
Overall F:
Illness Group 8.31 (2) .016* -
Contrasts:
DM2 Vs. No IU 
Other Vs. No 111 
DM2 Vs Other
.732
-.086
2.096(1)
.370(1)
6.74(1)
.052 NS 
.804 NS 
.005**
2.98
.917
2.26
.993
.465
1.28
4.357
1.81
4.01
*** P value (.818) from analyses in which other illness group was used as the indicator 
Purpose 2: Direct Effect of Social Support as a Predictor of an AD
In order to determine whether perceived social support was associated with a 
diagnosed affective disorder, social support was added to the LR model described 
above. As was previously defined, SS was defined by the average total score from the 
two ISEL administrations, converted to a z-score (mean = 0. SD = 1).
In block 3. SS was entered and a significant main effect was observed (X2 = 
35.47, df 5. p < .000). The significant main effect for SS suggested that perceived social 
support is beneficial for all medical illness groups in decreasing AD diagnoses when the 
main effects of illness, gender and education are controlled. As was hypothesized, 
higher rates of perceived social support were associated with lower rates of affective 
disorders for both the subgroup of patients with no chronic illness and those with type 2 
DM and other chronic illnesses. Thus, these results suggest a generic, overall beneficial 
effect of social support. Specifically, as illustrated in Table 18, the results of this LR 
indicated that for each standard deviation increase in social support, the corresponding 
odds of having an affective disorder decreased by a multiple of .618 or by 38.2%.
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Table 18: LR Results of Gender. Education. IG and SS
Variable P Wald(df) P Odds
Ratio
95% C.I. Odds 
Lower Upper
Gender .802 4.57(1) .033* 2.22 1.06 4.64
Education .181 9.57(1) .002** 1.19 1.06 1.34
Overall F:
Illness Group 6.78 (2) .034*
Contrasts:
DM2 Vs. No HI 
Other Vs. No 111 
DM2 Vs Other
.559
-.216
***
2.096(1)
.370(1)
6.74(1)
.148 NS 
.543 NS 
.009**
1.74
.806
2.17
.821
.402
1.20
3.727
1.61
3.89
Social Support -.482 12.34(1) .000** .618 .472 .808
*** p value (.775) from analyses in which other illness group was used as the indicator 
Purpose 3: Social Support as a Moderating Variable Between IG and AD
Logistic regression analyses was used to determine whether social support 
moderates the impact that having a medical illness has on the odds of having an 
affective disorder. For this series of analyses, gender and education were statistically 
controlled and the predictor variables were SS and IG and the interaction of SS and IG. 
It was hypothesized that a significant interaction between SS and IG would be observed, 
reflecting a greater beneficial effect of social support among those with type 2 DM. 
followed by the group with other chronic illness, with the least benefit being for those 
with no medical illness.
As described in purpose 2, gender and education were entered as a block I, 
followed by IG (block 2) and SS (block 3). In order to determine whether a moderating 
effect existed between SS and IG, block 4 involved forcing the interaction term 
(SS * IG) into the model. Results of this LR found a significant chi-square for the 
interaction term (A2 = 43.07, df 7, p < .000). As Table 19 indicates, results of the 
overall LR model in which gender, education, IG, SS, and the interaction of SS * IG 
were entered simultaneously, found a significant interaction effect (p < .032).
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Table 19: LR Results o f Gender. Education. IG. SS and IG X SS
Variable P Wald (df) P Odds
Ratio
95% C.I. for 
Odds 
Lower Upper
Gender .757 3.91(1) .048* 2.13 1.00 4.51
Education .185 9.66(1) .002** 1.20 1.07 1.35
Illness Group ----- 5.645 (2) .059 NS
Contrasts:
DM2 Vs. No 111 
Other Vs. No III 
DM2 Vs Other
.678
-.035
***
2.75 (1) 
.009(1) 
5.262(1)
.097 NS 
.926 NS 
.022*
1.97
.966
2.04
.884
.464
1.10
4.39
2.01
3.75
Social Support .310 .758(1) .384 NS 1.36 .679 2.74
Interaction: 
(IG X SS) 6.86 (2) .032* /
Contrasts:
DM2 Vs. No 111 
Other Vs. No 111 
DM Vs. Other
-1.12
-.824
****
6.83 (1) 
3.97(1) 
.860(1)
.009**
.046*
.354NS
.326
.438
.743
.141
.195
.397
.755
.987
1.392
Constant -3.97 19.85(1) .000** .020
***|3 value (.713) from analyses in which other illness group was the indicator 
****P value (-.297) from analyses in which other illness group was the indicator
Specifically, post-hoc comparisons revealed that when those with type 2 DM 
were compared with those with no medical illness, a significant interaction was found 
(p < .009). Explicitly, each standard deviation decrease in SS increased the odds of 
having an AD by .326 or by 67% for those with type 2 DM as compared to those with 
no chronic illness. Similarly, a significant interaction effect was also found when those 
with other illnesses were compared to those with no medical illness (p < .046). 
Specifically, each standard deviation decrease in SS increased the odds of having an AD 
by .438 or by 56% for those with other chronic illnesses as compared to those with no 
medical illness. However, when those with type 2 DM was compared to those with 
other chronic illnesses, no significant interaction was identified (Wald = .860, df 1, p  < 
.354). Hence, as is displayed in Figures 4 and 5 (See Appendix E), these results
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supported the hypothesis that social support serves as an important moderating variable 
for those with both type 2 DM and those with other chronic illnesses and appears to be 
more important for those with diabetes.
Purpose 4: Predictive Utility of each Type of Social Support
In order to determine whether there was a differential impact of each type of 
social support (appraisal, tangible, belonging, self-esteem), a backward stepwise LR 
was conducted. It was hypothesized that tangible social support would contribute 
significantly to a decrease in AD in those with type 2 DM due to the extensive self­
management requirements of this disease. In order to compare the association of each 
type of social support with the presence of an affective disorder, the outcome variable 
was AD and the predictors were IG and each SS subscale. First, gender and education 
were entered as block 1, followed by IG in block 2. Next, in block 3, all four SS 
subscale (converted into z scores) scores were entered simultaneously in a backward 
stepwise fashion. When entered simultaneously, all social support subscales yielded a 
significant chi-square (X2 = 34.04, df 5. p  < .000). Therefore, as a group, all four social 
support subscales were very predictive of an AD. However, as presented in Table 20, 
when backward elimination was used, only tangible support was retained in the model 
as a significant predictor of AD. Specifically, each SD increase in tangible social 
support decreased the odds of having an AD by a multiple of .642 or by 35.8%.
Given the identification of tangible social support as the only significant 
subscale variable retained, in the next LR, the tangible social support X illness group 
interaction term was forced into the model. As illustrated in Table 21, the interaction 
term missed significance at the p<.05 level, (Wald 5.00,2 df, p < .082). However, the
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interaction yielded the same pattern of results as the total score, indicating that tangible 
support may have a stronger protective function in patients with diabetes and other 
chronic illnesses than in those with no illness.
Table 20: LR Results of Gender. Education. IG and SS Subscales (Appraisal. Tangible. 
Self-Esteem, Belonging)
Variable P Wald (df) P Odds
Ratio
95% C.I. for 
Odds 
Lower Upper
Gender .820 4.78(1) .029* 2.27 1.08 4.75
Education .182 9.85 .002** 1.19 1.07 1.34
IG 6.39 (2) .041*
Contrasts:
DM2 Vs. No 111 
Other Vs. No 111 
DM2 Vs. Other
.602
-.143
its**
2.45(1)
.164
6.23(1)
.117 NS 
.686 NS 
.012*
1.82
.867
2.10
.859
.435
1.174
3.87
1.73
3.774
Tangible support -.443 11.15(1) .001 .642 .495 .833
Constant -3.80 19.63(1) .001 .022
***P value (.744) from analyses in which other illness group was used as the indicator
Table 21: LR Results of Gender. Education. IG. Tangible Support and the Tangible 
Support X IG Interaction
Variable B Wald (df) P Odds
Ratio
95% C.I. 
Lower Upper
Gender .796 4.34(1) .037* 2.21 1.04 4.68
Education .186 10.09(1) .001** 1.20 1.07 1.35
Illness group 5.45 (2) .065 NS
Contrasts:
DM2 Vs. No 111 
Other Vs. No 111 
DM Vs. Chronic
.654
-.038
***
2.70(1)
.011(1)
5.09(1)
.100 NS 
.916 NS 
.024*
1.92
.963
1.99
.882
.473
1.09
4.19
1.95
3.64
Tangible SS .268 .530 .466 NS 1.30 .635 2.69
Illness X Tangible SS 5.00(2) .082 NS
Contrasts:
DM 2/No 111 X Tangible 
Other / No 111 X Tangible 
DM2 / Other X Tangible
-.955
-.733
5.00(1)
3.01(1)
.549(2)
.025* 
.082 NS 
.459 NS
.385
.480
.801
.167
.210
.446
.889
1.09
1.44
Constant -3.94 20.51(1) .000** .019
***P value (.692) from analyses in which other illness group was used as the indicator 
♦ * * * P  value (-.222) from analyses in which other illness group was used as indicator
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DISCUSSION
This study provides a unique contribution to the literature by comparing the 
prevalence o f diagnosed depressive and anxiety disorders in a group of low-income 
patients with type 2 DM against those in the same cohort with hypertension, arthritis 
and asthma and those with no medical illness. Additionally, this study was the first to 
explore the moderating effects of social support on the incidence of affective disorders 
in primary care patients with type 2 DM. It was found that social support appears to 
make a difference in the emotional well-being of low-income, primary care patients 
with chronic illness.
The present sample consisted primarily of uninsured, socioeconomically 
disadvantaged African American, middle-aged females. Although it is estimated that 
6% of the U.S. population currently suffers from DM, a startling 32% of the current 
sample was diagnosed with type 2 DM. Further, an additional S0% of the sample 
suffered from hypertension, asthma and/or arthritis, and over 53% suffered from 
comorbid obesity. The fact that the majority of the sample experiences several risk 
factors for psychopathology (i.e., female gender, low-income, high rates of obesity), in 
addition to the observed high rate of chronic illness, increases the likelihood of 
comorbid psychopathology and underscores the importance o f identifying possible 
moderating factors.
Prevalence of Affective Disorders
Consistent with prior research examining the prevalence of depressive disorders 
in primary care populations (e.g., Schulberg et al., 1995) results of the current study 
identified that 10% of the sample met DSM-IV criteria for a depressive disorder
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occurring over the prior 12-month period. While fewer studies have examined anxiety 
in U.S. primary care samples. Orleans et al. (1985) concluded that the incidence of a 
current anxiety disorder can be expected in 15% to 18% of patients seen in primary care 
settings. The present study identified 10% of the total sample who met criteria for an 
anxiety disorder; however, an additional 9% suffered from both a depressive and an 
anxiety disorder occurring during the past year. Therefore, it can be estimated that 
approximately 19% of the present sample suffered from an anxiety disorder during the 
prior 12-month period, and 29% suffered from either a depressive or an anxiety disorder 
during the year. These results are at the high end of the 10% to 30% reported in prior 
epidemiological studies (Perez-Stable et al., 1990; Schulberg & Bums, 1988; Kirmayer 
et al., 1993).
The high prevalence of affective disorders identified in this sample can be 
explained by several possible factors. First, although methodological differences in 
community-based epidemiologic studies have resulted in inconsistent prevalence rates 
of affective disorder associated with the African-American population (Kessler et al., 
1994; Vernon and Roberts, 1982; Brown, Schulberg & Madonia. 1996), this minority 
group has consistently been shown to have higher rates of medical comorbidity, 
decreased physical functioning, and higher reported incidence of sleep disturbance 
(Weissman, 1987) than that found in Caucasian samples. These stress-inducing factors 
have been linked to higher rates of affective disturbance. Thus, the racial composition 
of the sample may have contributed to the observed elevated rates of depressive and 
anxiety disorders.
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The high prevalence of affective disturbance reported by this socioeconomically 
disadvantaged sample may also be indicative of the stress of living in an impoverished 
environment. Bruce, Takeuchi, and Leaf (1991) found that those living in poverty had a 
two-fold increased risk of an episode of at least one psychiatric disorder. Indeed, the 
greatest prevalence of mental health problems occurs among the lower socioeconomic 
groups. Additionally, this low-income, primary care population is characterized by 
other risk factors for stress including high rates of unemployment, low rates of health 
insurance coverage and severe financial hardship. These liabilities create a lack of 
available resources necessary to overcome the most prevalent stressful financial, 
medical and social situations and have been linked to higher rates of affective 
disturbance.
The predominance of women in the current sample (80%) inherently predisposes 
this group to higher rates of affective disturbance. Consistent with prior research, 
logistic regression results identified that the odds of having an affective disorder in 
women was approximately 100% higher than that of men. Biological research has 
implicated genetic factors and hormonal influences as essential variables for increased 
vulnerability to psychopathology in women. Additionally, multiple psychosocial 
stressors, including role overload, troubled relationships, losses and trauma also place 
women at increased risk of depression.
Results of the present study also identified education level as a unique 
contributor to the prevalence of an affective disorder; although, not in the direction 
expected. Research examining the social patterns of depression has consistently found 
higher levels of education to be associated with lower levels of depression (Ross &
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Wirowsky, 1989); however, results of the present study indicated that as the number of 
years of formal education increased, the corresponding odds of having an affective 
disorder also increased (at a rate of 16% per year of education). The finding that 
education contributed to an increased prevalence of affective disorders is consistent 
with the findings of Yokopenic, Clark and Aneshensel (1983). They reported that 
having more education enhanced recognition of depressive problems, thereby 
contributing to higher rates of problem identification and treatment seeking. Patients 
with higher levels of education have consistently been found to present with more 
cognitive and affective symptoms when describing their psychological disturbance, thus 
leading to increased identification and diagnostic accuracy as compared to lower 
educated patients, who are more likely to present with a higher number of somatic 
symptoms associated with psychological distress (Simon, Gater, Kisely and Piccinelli. 
1996). This tendency may be compounded by the presence of true medical 
symptomatology.
Lastly, the increased prevalence of affective disturbance identified in the current 
sample may be explained by the increasing trend for patients to utilize primary care 
practice for mental health care. Regier, Goldberg and Taube (1978) hypothesized that 
the high prevalence rates of psychiatric disorders in primary care settings are the result 
of patients using primary care settings to secure treatment for mental health problems.
It is now well documented that mental health concerns are one of the major health 
problems encountered in the primary health care setting. Katon and Schulberg (1992) 
found that more than 33% of consecutive primary care attendees reported substantial 
levels of psychological distress. This increased utilization of primary care settings to
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secure mental health care has been explained by the dramatic decrease in availability of 
state and county funded mental health services.
Although the prevalence rates of poverty have not significantly changed in the 
past decade, the availability of federal, state, and county-financed mental health services 
have considerably declined (Bruce et al., 1991). Mental health services have been 
drastically reduced to the point that only those individuals with severe psychiatric 
illness, who are at risk of hospitalization, are eligible for funded services. In addition, 
the influx of the managed care industry has resulted in decreased availability of 
specialty mental health services for the insured patient. Changes in the availability of 
mental health services have resulted in increased utilization of primary care providers 
for mental health treatment throughout the general population. Thus, given so few 
mental health services, the primary care sector is experiencing a deluge of patients 
seeking treatment for affective disturbance.
Following the identification of the overall high prevalence of affective disorders 
in the current sample, the next purpose of the present study was to examine the rates of 
DSM-IV depressive and anxiety disorders in patients with type 2 DM as compared to 
those with other chronic illness. Although the past decade of research has seen a 
proliferation of studies establishing a high rate of affective disorders in patients 
suffering from diabetes, few have attempted to examine those with type 2 DM in a 
comparison study against those with other chronic illnesses. Therefore, in order to 
determine if diabetes contributes uniquely to the presence of affective disorders, 
patients with type 2 DM were compared to those with no medical illness and to those 
diagnosed with hypertension, asthma and/or arthritis.
87
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Type 2 DM Vs. Other Chronic Illnesses in the Incidence of AD
Once the contribution of gender and education was statistically controlled, 
logistic regression results indicated that type 2 DM contributed uniquely to the 
prediction of affective disorders above that identified in patients with hypertension, 
arthritis and asthma. Indeed, those with type 2 DM were found to increase the odds of 
experiencing an affective disorder by 126% when compared to those suffering from the 
other chronic illnesses examined in this study. Although the prevalence of type 2 DM 
has been documented to be twice as high in women (ADA, 1999), these findings were 
only evident after the contribution of gender and education were parceled out.
Therefore, it appears that factors related to type 2 DM place an individual at increased 
risk of an affective disturbance above that associated with gender and chronic illness in 
general.
A higher prevalence of affective disturbance in patients with type 2 DM can be 
expected given the extensive self-management demands of this chronic illness. Daily 
management of diabetes can be demanding as it often involves controlled dietary intake, 
social interference, exercise requirements, weight loss and the threat of long-term 
functional impairment. Perhaps most important from a psychological and behavioral 
perspective, patients must adhere to the demanding requirements of DM management 
while knowing that eventual onset o f complications is almost inevitable, thus 
contributing to increased stress.
Nevertheless, these results conflict with those found by Weyerer et al. (1989) 
who identified that although patients with diabetes (types 1 and 2) had a higher 
prevalence o f psychiatric impairment than those with no somatic illness, no differences
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were noted when they were compared to those with other somatic illnesses. However, 
their study included predominantly Caucasians with both types 1 and 2 DM who 
volunteered to participate in a community field study. Additionally, in the Los Angeles 
part of the Epidemiologic Catchment Area Program. Wells et al. ( 1988b) provided data 
on psychiatric disorders and eight chronic medical conditions in a community sample of 
2554 adults. This study revealed that although most chronic medical illnesses were 
strongly associated with psychiatric disorders, diabetes was not. However, the 
diagnosis of diabetes was not validated by physician examination. Given that a large 
U.S. study revealed that approximately 50% of those who meet criteria for diabetes do 
not know that they are diabetic (Kovar, Harris & Hadden, 1987), highlights this as a 
significant limitation. The results of this study indicate that patients with type 2 DM 
significantly differ from those with other chronic illnesses in the prevalence of affective 
disorders.
These results support prior research (Penninx et al., 1998; Folkman & Lazarus, 
1980) that chronic stress related to medical disorders serves as a strong predictor of the 
development of psychopathology and suggests that diabetes contributes uniquely to an 
increased prevalence of affective disturbance in a low-income, primary care population 
with chronic medical illnesses. Given that an extensive literature has revealed that 
social support may contribute to the variability in the impact of chronic illness on 
psychological health, the next purpose of the present study was to determine whether 
perceived social support was negatively associated with affective disturbance in low- 
income, primary care patients.
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Social Support
Chronically ill patients who receive considerable social support have been found 
to be at decreased risk of subsequent psychopathology. Prior research has identified 
that the efficacy of social support resources may depend on the type of support available 
and the specific characteristics of the stressor (i.e., disease). Therefore, in order to 
examine whether social support has an overall beneficial effect of decreasing the 
incidence of affective disorders, the effects of social support were examined in those 
with and without medical illness. Results indicated that social support provides a 
generic, overall beneficial effect, thereby supporting the apriori hypothesis that social 
support is a moderating variable for low-income, primary care patients with and without 
a chronic medical illness. However, a significant interaction effect was also identified 
between social support and illness group.
Results indicated that social support was more beneficial for patients in both 
chronic illness groups: however, no buffering effect was identified in patients with no 
chronic medical conditions. The traditional buffering hypothesis states that the impact 
of stress on mental health is stronger when social support is low. Additionally, the 
association between social support and mental heath is stronger under conditions of 
high versus low stress (Kessler & McLeod, 1985). Additionally, Wheaton (1983) 
argued that buffering might be more pronounced for chronic rather than acute stress. 
The findings in the present study support both of these hypotheses and lead to the 
conclusion that in a sample of chronically ill, low-income, poorly educated, primary 
care patients with multiple sources of stress, social support contributes to improved
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emotional well-being. However, the association between chronic illness, social support 
and affective disorders may not be so direct.
Affective disturbance, social support and type 2 DM may be related by several 
possible mechanisms that are not mutually exclusive. For example, depression and/or 
anxiety symptoms may arise from the direct biological effects of chronic medical 
diseases: from the personal meaning of the illness, or from the reaction of the individual 
and his social support network to the disability and discomfort associated with daily 
management of a long-term illness. In addition, psychosocial complications of illness, 
including loss of income or employment and possible disturbances in family and social 
relations, may also contribute to the development of affective disturbance.
The “buffering model” of social support is based on the assumption that social 
support serves a protective function with respect to mental health when individuals are 
faced with stressful life circumstances (Cohen and Wills, 1985). In medical patients, 
the degree of stress associated with disease may be related to emotional loss, physical 
impairment, lifestyle interference, or threatened disability. Fitzpatrick et al. (1988) 
tested the moderating effect of social support in severely impaired rheumatoid arthritis 
patients, however, evidence for a buffering effect was not found. However, they 
measured social support using a scale designed to assess the emotional aspects of social 
support (appraisal, belonging, self-esteem), which may be most important for those 
whose needs for physical support are not high. Among the medically ill, these aspects 
of social support may be effective buffers; however, other aspects of social support may 
be more relevant.
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Thus, in the present study, it was hypothesized that among those with disabling 
medical illnesses (i.e., type 2 DM), more substantive forms of social support (i.e., task 
completion, transportation assistance, financial aid, coping with illness-related deficits) 
would be the most significant aspects of support. In an effort to determine whether 
tangible social support would be more protective of low-income patients coping with 
multiple sources of stress, each of the four types of social support assessed by the ISEL 
was independently evaluated. After analyzing the data using a backward elimination 
logistic regression, tangible social support emerged as the strongest predictor of 
affective disturbance for the entire sample of participants. However, each of the four 
social support subscale scores were so highly correlated that none contributed uniquely 
to the prediction of an affective disorder. Therefore, although it appears that tangible 
support is an important buffer for affective disorders in those coping with the daily 
stress associated with socioeconomic disability, multiple chronic health concerns, and 
lack of health insurance, emotional sources of support appear to be equally as 
important.
The identification that both tangible social support and the more emotion- 
focused types of support were so highly correlated in this sample raises the issue of 
adequacy in the operationalization of the construct of social support. In order to 
demonstrate that these conceptually different functions of support are related to health, 
it is important to demonstrate that the measures of the different support functions are 
distinguishable in function (House & Kahn, 1985). Sarason, Pierce, and Sarason (1987) 
found that the four social support scales correlated highly with one another, suggesting 
that they measured the same construct. Similarly, Schonfeld (1991) reported that the
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appraisal, tangible and belonging scales were moderately correlated with each other and 
suggested that the tentative nature of the reliability of the difference scores suggests that 
the ISEL scales are not multidimensional. Brookings and Bolton (1988) also identified 
large correlations among the four factors suggesting a general second-order social 
support factor; however, they suggest that the four subscales provide sufficiently unique 
information to warrant maintaining the four subscale scores in the measure. 
Nevertheless, there is sufficient information to suggest that the construct of tangible 
support is not adequately tapped by the questions on the ISEL. However, this issue may 
also be examined from a construct perspective.
The present finding of an absence of clearly delineated social support 
dimensions reflected in the ISEL subscales is consistent with a number of prior research 
findings (Schonfeld. 1991; Sarason et al., 1987). Therefore, it is possible that the 
overlap in the scales reflects a characteristic inherent to social support. That is, when 
one type of support is activated, a conceptually different type of support is also 
mobilized (Schonfeld, 1991). For example, if a person responds to a tangible-support 
item on the ISEL by strongly agreeing that they could find someone to help them with 
their chores if sick, it is likely that those providing that type of tangible support would 
also be a source of emotional provisions. Namely, this very support person would also 
be likely to supply advice (appraisal), encouragement (self-esteem) and companionship 
(belonging) to the ill respondent. Therefore, future studies investigating the influence 
of social support are advised to examine the adequacy of the measurement instruments 
employed in assessing support functions.
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In conclusion, in a low-income, primary care population with multiple sources 
of stress, it appears that patients with chronic illness may benefit both from concrete, 
daily assistance with task completion and assistance with illness-related activities; 
however, more emotion-focused sources of support are also important in buffering the 
association with affective disturbance.
Intervention Implications 
These results suggest important implications for the recognition of affective 
disorders in this low-income. primary care population. Particularly, the high rate of 
affective disorders found in this sample of primary care patients, emphasizes the need 
for screening measures that sensitize clinicians to the presence of affective disorders. 
Additionally, given that social support clearly makes a difference in the emotional well­
being of patients with chronic illness, increasing sources of social support for patients 
with chronic illness may significantly decrease the prevale nee of depression and 
anxiety. Increasing social support in the primary care setting may be accomplished by 
offering educational seminars, peer support groups and provisions for transportation, 
child care and medical supplies.
Additionally, encouraging patients to utilize family, community and regional 
resources may assist in providing tangible resources in addition to increasing a sense of 
belonging. Because family efforts to help those with diabetes have been associated with 
negative emotional responses (Bailey & Kahn, 1993), dyadic or group counseling for 
those with diabetes and their primary support providers may facilitate social support by 
increasing the clarity of communication and modeling new ways to offer, receive and 
refuse assistance.
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Limitations and Future Directions 
Several methodological and theoretical limitations may have contributed to the 
findings in the present study. This study was conducted with predominantly low- 
income, poorly educated, primary care patients. Therefore, the first limitation of the 
current study pertains to the lack of generalizability of the results. The results of the 
present study may be limited to similar primary care populations: that is low-income, 
African-American, females. Although the intention of the current study was to evaluate 
this high-risk population in order to determine the prevalence of affective disorders and 
the association of social support, these results should not be assumed to apply to all 
low-income patients in other settings and in other demographic regions.
A second limitation pertains to the possibility that other demographic and 
medical factors, not examined in the current study, serve as more powerful predictors of 
affective disturbance in this population. Although a good deal of effort was made to 
control for demographic risk factors for affective disorders, factors which may be 
associated with increased affective impairment may not have been evaluated. Perhaps 
most important, degree of functional impairment associated with disease was not 
adequately assessed.
Previous research suggests that psychological distress increases in relation to 
physical impairment, although this relationship is not necessarily linear (Littlefield, 
1990). The role of social support as a protective factor with respect to mental health 
may be most apparent in individuals faced with particularly stressful life circumstances 
(Cohen & Wills, 1985). In medical patients, if degree of physical impairment is 
regarded as a stressor, the moderating effect of social support should be most apparent
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for patients who are more impaired. Litdefield et al. (1990) examined the association 
between social support and level of severity of type 1 diabetic illness. Indeed, they 
found that depressive symptoms, as assessed with the Beck Depression Inventory, 
positively correlated with functional impairment and that social support moderated 
depression in the face of greater functional impairment.
Future studies are recommended to examine degree of functional incapacitation 
in order to establish consistent differences in affective disorders across medical 
illnesses, thus providing more support for a disease-specific model of illness. Although 
the results of the present study suggest that low-income adults with type 2 DM may be 
at increased risk for affective disorders (i.e.. a disease-specific model), other illness 
factors (disease severity, duration of disorder) were not assessed. Further identification 
of stressors relatively unique to a particular disorder, as well as those common across 
disorders, may assist in elucidating factors contributing to increased affective 
disturbance and assist clinicians in planning interventions.
From a statistical point of view, this study is limited by sample size. Although 
power analyses were conducted prior to the onset of the study and the original sample 
size possessed adequate power to detect modest effects with an alpha < .OS for chi- 
square and logistic regression analyses, when the sample was divided into each of three 
illness groups and further divided into four psychiatric diagnostic groups, the cell sizes 
were decreased dramatically. Therefore, future studies are recommended to attempt to 
replicate these findings using larger sample sizes.
Finally, the standard limitations regarding cross-sectional, behavioral research 
apply to the present study. First, causal interpretations pertaining to the development of
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affective disorders given lower rates of social support are discouraged. However, these 
results suggest a causal link which may be identified with a longitudinal design. Future 
studies are recommended to examine the influence of high and low levels of social 
support as variables in the development of affective disorders in patients with diabetes 
versus those with other chronic diseases. Second, the use of self-report to determine 
social support opens the door to the possibility of response bias. Future studies are 
advised to utilize additional objective assessment methods including other-report, direct 
behavioral observation, and/or daily monitoring. A multi-modal assessment would 
account for this possible confound and would serve to strengthen the confidence of the 
present conclusions.
Summary
Despite the limitations mentioned above, the present study contributed unique 
findings to the literature pertaining to affective disturbance. social support and type 2 
DM. This study represents one of the first to examine the DIS-IV determined 
prevalence of affective disorders in primary care patients with type 2 DM as compared 
to those with hypertension, asthma, and arthritis. Results support prior research that 
the prevalence of affective disturbance is high in primary care samples and suggests that 
type 2 DM contributes uniquely to both depressive and anxiety disorders in low-income 
patients. The present study also served to advance the literature by evaluating the 
association of social support and affective disorders across those with and without 
chronic illnesses. Results indicate that social support is an important moderator of 
affective disorders for patients with chronic illness. These findings have important 
intervention implications for primary care practice including increasing efforts to
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diagnose and treat affective disturbance in low-income patients and offering supportive 
services and/or encouraging patients to utilize the supportive services offered by 
community resources.
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APPENDIX A: DEMOGRAPHIC QUESTIONNAIRE
I. Subject Number:  2. Age: __________________________
3. Medical Record # :______________  4. Clinic: ( ) Medicine ( )  Family Practice
5. Sex (Circle one): Male Female 6. Job/Occupation:_________________
7. Marital Status: (Circle one)
Single
Married
Separated
Divorced
Other (Specify)________
8. Race (Circle one):
White (Non-Hispanic)
African-American
Hispanic
Asian
Other: (specify)___________
9. What is the highest grade you have completed:
Grade school (1 -12): ________
College/Trade school: ________
Have you completed high school (circle one): Yes No
If you have not graduated from high school: do you have a GED? Yes No
10. Other education (please specify type and number of years):
11. What is your average monthly income? $________________
Where does this money come from? (circle each one that applies to you and 
indicate the amount of money you receive from that source each month)
My job/career $.
Public assistance/Welfare $.
Social Security/Disability $.
Umemployment S.
Child Support/Alimony $.
Allowance $.
Other sources:
  $.
  $ .
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12. How many people are in your home?
What is the total monthly income including everyone in your home?_______
Where does this money come from? (circle all that applies to your family and 
indicate the amount of money your family receives from that source each 
month)
My job/career $_________________
Public assistance/Welfare $_________________
Social Security/Disability $_________________
Umemployment $_________________
Child Support/Alimony $_________________
Allowance $_________________
Other sources:
  $____________________
  $____________________
13. Have you ever received treatment for a mental health problem? Yes No
What kind of problem?_____________________________
14. Have you ever received treatment for a drug or alcohol problem? Yes No
What kind of problem? _____________________________
15. Do you have any health insurance? Yes No
If yes. what k ind?_________________________________________
16. Your address: _____________________________________________
17. Your phone number: ________________________________________
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APPENDIX B: INSTITUTIONAL REVIEW BOARD APPROVAL
Institutional Review Board 
Louisiana State University 
Baton Rouge Campus
(504) 345-3145 FAX (504)346-5705
APPROVAL DATE: July 18,1995
FROM:
TO:
RE:
Institutional Review Board 
Dr. Phillip Brantley
Pennington Biomedical Research Center 
Proposal No. 1871
This is to certify that a quorum of the Institutional Review Board reviewed the 
proposal entitled:
Strns n d  Psychopathology in Medical Utflhatfon.
The committee evaluated the procedures of the proposal following the guidelines 
established for activities supported by federal funds involving as research
subjects.
A review of this proposal by the Committee will be considered at least on an annual 
basis, and at more frequent intervals depending on the element of risk.
Recommendation o f Committee: X APPROVED
JNOT APPROVED
Comments: License No. 72-3
Multiple Assurance No. Ml 128
W. Sheldon Bivin, Chairman
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APPENDIX C: INFORMED CONSENT FORM
LOUISIANA STATE UNIVERSITY MEDICAL CENTER IN NEW ORLEANS
CONSENT FORM
1. Study Title: The Roles of Stress, Social Support, and Psychopathology in Primary 
Care Utilization.
2. Performance Site: Family Practice and General Medicine Clinics at Earl K. Long 
Medical Center, Baton Rouge, Louisiana.
3. Names and Telephone Numbers of Investigators:
For 24-hour access, please call Isabel Scarinci at (504)358-1105.
John Howe, M.D. (504) 358-1103
Janet L. Thomas (504) 358-3927
Glenn N. Jones, Ph.D. (504) 358-1105
Phillip J. Brantley, Ph.D. (504) 358-1105
4. Purpose of the Study . This is a research study to determine the roles of stress, mental 
health, social support, and coping strategies in primary care utilization.
5. Subject Inclusion Criteria: Male and female volunteers ages 18 and older who are 
patients in the EKL Department of Family Medicine or EKL General Medicine Clinic 
will quality as subjects in this research project.
6. Subject Exclusion Criteria: Subjects will be excluded from Phase II o f the project for 
not having a telephone at home.
7. Description of the Study: This is a research study to determine the roles of stress, 
mental health, social support, and coping strategies in primary care utilization. Subjects 
will participate in the study in two phases. Subjects do not have to participate in Phase 
II to participate in Phase I. Subjects must participate in Phase I to participate in Phase 
Q. In Phase L subjects will be chosen from waiting rooms at the EKL Department of 
Family Medicine and General Medicine Clinics. Subjects who agree to will complete 
the demographics questionnaire and the General Health Questionnaire (GHQ).
Phase II of this project will be divided into 4 tasks:
(1) Subjects will complete the following questionnaires on the same day: the 
Interpersonal Support Evaluation List (ISEL) (a measure of social support), the Ways of 
Coping Questionnaire, (WOC) (a measure of coping strategies), the Weekly Stress 
Inventory (WSI) (a measure of minor stress), the 1994 Behavioral Risk Factor 
Questionnaire (a measure of health risk behaviors), and the Ways o f Religious Coping 
Scale (a measure of religious coping).
(2) Subjects will be asked to complete the WSI and a self-report hospital utilization 
questionnaire (SRU) bimonthly for one year, and in the sixth month the Life 
Experiences Survey (LES) (a measure o f major stressors) will be added to the phone 
interview. A research assistant will contact subjects by telephone once every other
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month in order to collect the responses to these questionnaires and to answer any 
questions subjects may have;
(3) One year after the initial contact, subjects will be scheduled to complete the 
following at the Center for Primary Care Research at EKL: (a) Composite International 
Diagnostic Interview (CIDI) (a mental health interview), (b) ISEL, (c) WOC, and
(d) SRU.
(4) Subjects will be contacted by telephone 3, 6 ,9  and 12 months following the 
interview and asked to answer the SRU.
8. Benefits to Subject: At the end of study, subjects will be provided with a summary 
report of findings and their relevance to primary care utilization, at their request. If 
needed, subjects will receive a referral to an appropriate agency.
9. Risks to Subject: No known physical risks. Participation in this study may involve 
unforeseen risks.
10. Alternatives to Participation in the Studv: Since no treatment is involved in this 
study, the only alternative to participation in the study is not to participate.
11. Subject Removal: Subjects will be removed form the study if they fail to complete 
(1) Phase I: (2) part 1 of Phase II; (3) 80% or more of requested bimonthly interviews; 
(4) part 3 or 4 of Phase II. There is no risk involved in being removed from the study.
12. Subjects Right to Refuse to Participate or Withdraw: Study subjects may refuse to 
participate or withdraw from the study at any time without jeopardizing, in any way, 
their medical treatment at this institution in the present or fiiture. Should significant 
new findings develop during the course of the research, which may relate to the 
subject’s willingness to continue participation, that information will be provided to the 
subject. There are no special risks involved in withdrawal from the study.
13. Subjects Right To Privacy: The results of the study may be released to the funding 
agency. The results of the study may be published. The privacy of subjects will be 
protected and they will not be identified in any way.
14. Release of Information: The medical records related to the study are available to the 
sponsoring agency. Information provided during the course of the study is confidential. 
The only exceptions are in cases where subjects indicate suicidal desires, homicidal 
desires, or child abuse. In these instances, the researchers are ethically and legally 
required to inform their supervisor regarding the subject’s desires.
15. Financial Information: A. Participation in this study will not result in any extra 
charges beyond those routinely incurred by patients with similar illnesses. B. The costs 
o f the study related to unforeseen complications must be met by subjects. C. Subject 
Payment: Subjects will be paid $15 (fifteen dollars) for completing Phase I of the study. 
Subjects will be paid $20 (twenty dollars) for completing part 1 of Phase n . Subjects 
will be paid $10 (ten dollars) for each telephone interview completed during part 2
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Phase II. Subjects will be paid $50 (fifty dollars) for completing part 3 of Phase II and 
$10 (ten dollars) for each phone interview completed during part 2 Phase Q. Subjects 
will be paid $50 (fifty dollars) for completing art 3 of Phase II and $10 (ten dollars) for 
each phone interview completed during part 4 o f Phase Q.
16. Signatures: The study has been discussed with me and all my questions have been 
answered. I understand that additional questions regarding the study should be directed 
to investigators listed on page one of this consent form. I understand that if I have 
questions about subjects rights, or other concerns, I can contact the Chancellor of the 
LSU Medical Center, at (504) 568-4800. I agree to the terms above and acknowledge I 
have been given a copy of the consent form.
Signature of Subject Date Signature of Witness Date
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APPENDIX D: DEMOGRAPHIC PROFILE OF THE ORIGINAL SAMPLE
Categorical
Variable
Frequency 
N= 403
Percent
Gender:
Female 324 80.4
Male 79 19.6
Race:
Black 295 73.2
White 108 26.8
Marital Status:
Married 150 27.2
Single 109 37.4
Other 142 35.4
Job Status:
Unemployed 233 59.0
Employed 162 41.0
Insurance:
None 312 77.6
Medicare 34 8.5
Medical 27 6.7
Private 29 7.2
Continuous Variable Mean SD Range
Age 45.60 13.94 18-78
Education level 11.13 2.68 0-16
Income 487.87 441.29 0-3600
BMI 31.03 8.56 14.9-70.6
# chronic illnesses 2.48 1.46 0-8
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APPENDIX E
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Figure 4: Linear Model of Social Support (X) as a Moderating Variable Between 
Illness Group and Affective Disorders as Determined By Logged Odds (B)
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Figure S: Odds of Having an Affective Disorder Diagnosis for Females with 11.3 
Years of Education for Each Illness Group with Social Support as a Moderating 
Variable
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